









Cerebral Manifestations of Preeclampsia
Cerebrale manifestaties in preeclampsie
Ingrid Anna Brussé
ISBN: 978-94-6169-980-0
Copyright © 2016 I.A. Brussé
No part of this thesis may be reproduced, stored in a retrieval system of any nature, 
or transmitted in any form by any means, without permission of the author, or the 
copyright-owing journals for previously published chapters
Cover:  Schilderij van Merel Kusters 
 Optima Grafische Communicatie, Rotterdam, The Netherlands
Lay-out:  Optima Grafische Communicatie, Rotterdam, The Netherlands
Printing: Optima Grafische Communicatie, Rotterdam, The Netherlands
This research was financially supported by Nuts-Ohra







Cerebral Manifestations of Preeclampsia
Proefschrift 
ter verkrijging van de graad van doctor aan de 
Erasmus Universiteit Rotterdam 
op gezag van de rector magnificus 
Prof.dr. H.A.P. Pols
en volgens besluit van het College voor Promoties. 
De openbare verdediging zal plaatsvinden op 















Voor Merel en Daan
Contents
Chapter 1: Introduction 9
Chapter 2: Electroencephalography during normotensive and 
hypertensive pregnancy: A systematic review
17
Chapter 3: Electroencephalography in normotensive and hypertensive 
pregnancies and subsequent quality of life
37
Chapter 4: Visual evoked potentials in normotensive and hypertensive 
pregnant women
57
Chapter 5: Cerebral perfusion pressure in preeclamptic patients is 
elevated even after treatment of elevated blood pressure
71
Chapter 6: Electromyographically recorded patellar reflex in 
normotensive pregnant women and patients with 
preeclampsia
81
Chapter 7: Impaired maternal cognitive functioning after pregnancies 
complicated by severe preeclampsia:  a pilot case-control 
study
95
Chapter 8: General discussion 107
Chapter 9: Summary | Samenvatting 119





The city through children’s eyes
Mede mogelijk gemaakt door:
Merel Kuster - groep 8 - Mullerpier









Ten to 15% of all pregnancies are complicated by de novo hypertension (1).  Gestational 
hypertensive disease includes pregnancy induced hypertension and preeclampsia 
presenting as various phenotypes. In about one third these pregnancies hypertension 
is accompanied by proteinuria and in 4-12% of these cases additionally complicated 
by the HELLP (Hypertension Elevated Liver Enzymes Low Platelets) syndrome. Due to 
generalised endothelial damage there is a multiorgan disease with disturbances in the 
hematologic system (hemolysis), coagulation cascade (diffused intravascular coagula-
tion), glomerular endotheliosis and liver cell damage.
About one-third of the preeclamptic patients show dysfunction of the central nervous 
system. Symptoms include headaches, increased tendon reflexes, eclampsia, visual 
disturbances (flashes, altered colour sensations, visual field loss and cortical blindness) 
and strokes (both hemorrhagic and ischemic) (2, 3). It can result in maternal death as the 
ultimate complication. Many former patients after a severe preeclampsia have problems 
to return to normal life (4).
The internal organs involved in the pathophysiology of preeclampsia can well be 
monitored with routine biochemical tests. In the current clinical setting the neurologi-
cal effects can, however, hardly be monitored by objective measures, while 71 % of the 
maternal deaths due to preeclampsia are caused by cerebrovascular accidents (5).
In a pilot study performed by our research group, Electroencephalography (EEG) was 
performed in 12 preeclamptic patients and 12 healthy pregnant controls. We studied 
them in pregnancy and 6 weeks postpartum. In preeclamptic patients significantly more 
EEG alterations were found as compared to the pregnant controls both in pregnancy as 
well as postpartum (6). 
Others showed EEG abnormalities in up to 80% of the postictal eclamptic patients. It 
is not known whether these were already present before the onset of the eclampsia (7). 
Therefore, in this thesis different phenotypes of gestational hypertensive disease were 
investigated to learn more about the presence of (sub-)clinical cerebral changes.
A rough way to be informed about brain function, especially consciousness, can be 
by measures like the Glasgow Coma Score. Furthermore, information can be obtained 
by imaging techniques like Magnetic Resonance Imaging (MRI), functional-MRI (fMRI) or 
Computer Tomography (CT). An adequate measure for brain function in hypertensive 
disorders of pregnancy has still to be developed. In this thesis we chose to elaborate on 
neurophysiologic measures.
The basis of cerebral neurophysiological investigation is Electroencephalography 
(EEG), which gives an overview of the brain function with modest spatial but very high 
temporal resolution. The EEG is sensitive to detect cerebral hypoxic changes (8). Since 
about one-third severe preeclamptic patients show symptoms of visual disturbances, 
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possibly related to brain function, the study of Visual Evoked Potentials (VEP) can also 
be informative. Maternal hemodynamics is also disturbed, which can be studied with 
Transcranial Doppler sonography.
In routine obstetric clinical practice the neurologic agitation level of the preeclamptic 
patient is monitored with blood pressure measurements together with the assessment 
of patellar reflexes. An agitated and hypertensive patient is considered at risk for an 
eclamptic fit. 
The interpretation of the patellar reflex is subjective with high inter- and intraobserver 
variability (9). In the medical literature there are no studies available on the quantifica-
tion of these reflexes with Electromyography (EMG) in hypertensive pregnancy. Therefor 
we also assessed the patellar reflex in these patients with EMG in a quantitative way. 
General aim of this thesis
This thesis intends to describe and explain the course of clinical neurophysiological and 
neuropsychological parameters in patients with hypertensive disorders in pregnancy. 
We aimed to improve knowledge on cerebral pathophysiological mechanisms of pre-
eclampsia related to signs and symptoms and to explore whether measuring features 
of these mechanisms with neurophysiological techniques can help to optimize timing 
of delivery in order to minimize maternal morbidity and maximize neonatal outcome.
this thesis contains 9 chapters:
After this introduction this thesis opens with a systematic review of the literature on EEG 
during normotensive and hypertensive disorders of pregnancy (chapter 2). Publications 
on this subject are of relatively old date and often not consistent with current clinical 
guidelines or medical terminology. Therefore, further research is needed to investigate 
the clinical value of implementing EEGs in the assessment of preeclamptic patients.
In chapter 3 a study is presented on EEG during pregnancy and postpartum, both 
in normotensive and hypertensive women. Subsequent quality of life was tested 
postpartum, using Health related quality of life (HRQoL) questionnaires with physical, 
psychological and social domains. In chapter 4 the results are shown of a study on visual 
evoked potentials (VEPs) in normotensive, chronically hypertensive and preeclamptic 
women.
As cerebral perfusion pressure (CPP) is elevated in preeclampsia (10), CCP was studied 
in preeclamptic women and healthy pregnant controls in chapter 5. We estimated zero 
flow pressure (ZFP) and CPP using simultaneously obtained arterial blood pressure 







The study in chapter 6 compared electromyographically recorded patellar reflex in 
normotensive and preeclamptic pregnancies.
In chapter 7 the neuropsychological outcome is presented of women three to eight 
months after severe preeclampsia. We compared a group of formerly preeclamptic 
women with a group of women with previous normotensive pregnancies, using a bat-
tery of neuropsychological tests.
Chapter 8 and 9 provides a general discussion and a summary of this thesis.
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Abstract
The objective of this review was to evaluate the available medical literature concerning 
the electroencephalogram (EEG) during hypertensive disorders of pregnancy. All articles 
found during a MEDLINE and Embase database search on the subject of EEG differ-
ences associated with hypertensive disorders in pregnancy were screened for elegibility. 
Twenty-two articles which describe the EEG during preeclampsia (PE)/ eclampsia were 
retrieved. Abnormal EEG findings were observed in the majority of the preeclamptic/
eclamptic patients, consisting of slow waves most frequently localized in the occipital 
lobe, as well as  spike discharges. The EEG abnormalities in PE/eclampsia were reversible 
in the majority of cases. We conclude that these described abnormalities may be inter-
preted as a warning sign of deterioration of brain function in PE/eclampsia. However, 
some caution regarding this conclusion is advised because most of the retrieved articles 
were published in the 1950s and 1960s, and were not consistent with current clinical 
guidelines or medical terminology. Further research is needed to establish the clinical 
value of implementing EEGs in the assessment of the preeclamptic/eclamptic patient.
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Hypertensive disorders of pregnancy (pregnancy induced hypertension (PIH), pre-
eclampsia (PE) and eclampsia) affect at least 5-8% of all pregnancies and are a leading 
cause of global maternal and infant morbidity and mortality (1). In developed countries, 
related maternal mortality is primarily caused by cerebrovascular complications (2).
According to the criteria of the International Society for the Study of Hypertension in 
Pregnancy (ISSHP), PIH is defined as de novo hypertension after 20 weeks of gestation, 
PE as the combination of hypertension and proteinuria (3). The severity of PE can be 
defined according to the criteria of the American College of Obstetricians and Gynecolo-
gists (ACOG) (4). A serious complication is an eclamptic seizure, resembling an epileptic 
grand mal seizure.
Deterioration of the preeclamptic symptoms and prevention of maternal complica-
tions can solely be achieved by delivery of the fetus and placenta. At present, the timing 
to terminate the pregnancy is predominantly based on clinical assessment, taking in 
consideration gestational age.
In pregnancies complicated by hypertensive disorders, neurological symptoms like 
headache and visual disturbances are important symptoms possibly reflecting brain 
function disorders. Electroencephalography (EEG) is known to be a sensitive method to 
detect brain dysfunction. EEG changes can be found before clinical symptoms are present 
and before ischemic conditions may result in irreversible brain dysfunction (5). So far, EEG 
changes do not play a role in the assessment and management of (pre-)eclamptic patients.
The aim of this review was to study the literature on EEG findings in hypertensive 
disorders of pregnancy. To our knowledge, no reviews on this subject have been pub-
lished so far. To improve the interpretation of the reported results, we also reviewed the 
literature on EEG differences in (young) men and women, during the menstrual cycle 
and in normotensive pregnant and non-pregnant women.
Background
electroencephalography
Electroencephalography is a method to record the electrical activity generated by the 
brain. The electrical activity of the brain reflects the normal function of active neuronal 
networks. Abnormal brain function is often reflected in changes in this electrical activity, 
especially for more acute and extensive lesions. As such, EEG changes are in general 
not very specific, but have a fair to good sensitivity for the detection of, for instance, 
cerebral hypoxia. In addition, EEG is the only method to detect electrical epileptiform 
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activity. Findings like spike-wave complexes have a high sensitivity and specificity in the 
diagnosis of an epileptic disorder.
Routinely EEGs are recorded by the 10-20 International System of Electrode Placement. In 
this system the names and location of the electrodes are specified and related to the brain 
areas (frontal, central, temporal, parietal and occipital). In most clinical applications, 19 
recording electrodes (plus ground and system reference) are used. Registrations are made 
for a period of 20 to 30 minutes, including standardized provocations like light flash stimu-
lation and hyperventilation, and usually a period of light sleep for 15 minutes is allowed. 
The various EEG activities can be divided into background activity, focal abnormalities, 
and intermittent and paroxysmal activity. The background activity consists of alpha-, 
beta-, delta- and theta-activity (see textbox). In reviewing the EEG, abnormalities in 
waveform, frequency, amplitude, symmetry, and reactivity patterns (i.e. slow waves or 
spikes/spike-wave complexes) are documented, including the localization (focal versus 
diffuse/generalized). In clinical practice, assessment of the EEG is largely based on a 
visual review of the recording and is hindered by large inter-individual variation.
Frequency spectral analysis like Fast Fourier analysis is a quantitative EEG (qEEG) 
method used to objectively quantify the contributions of the various frequencies, for 
instance in the conventional frequency bands (see textbox). The amount of activity in a 
certain frequency band can be expressed as power (squared amplitude), as an absolute 
value, or in relation to the total power of all frequencies in the spectrum. Another vari-
able from a power spectrum may include the frequency corresponding to a prominent 
peak in the spectrum (like the alpha peak frequency). The alpha peak frequency is one 
of the more reliable variables for which reference values are available.
textbox
Frequency bands of the eeG (9)
Waves Frequency Description
Delta 2.0~3.75 Hz They are present in babies, certain forms of encephalopathy and during 
sleep
Theta 4.0~7.75 Hz They are present in children, during snoozing, (day) dreaming, light sleep 
and just before waking up or falling asleep. They can be generated by 
trance or hypnosis
Alpha1 8~9.75 Hz Important activity in the alpha-range is the so called alpha-rhythm. This 
rhythm is characterized by an occipital localization and suppression by 
opening of the eyes
Alpha2 10.00~12.75 Hz
Beta1 13.00~19.75 Hz If they have low amplitude and multiple frequencies they are related to 
intensive thought and concentration. Rhythmical beta-waves with many 
pronounced frequencies reflect pathological or drug-related causes
Beta2 20.00~30.00 Hz
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eeG differences between men and women
Nine articles describe EEG differences between men and women (6-15). For individuals 
aged 20 to70 years, the power of the theta and beta-frequencies are higher in females 
in most derivations, whereas the power of the alpha-frequency is higher in males in 
the parieto-occipital derivations (13, 15). Females have a greater asymmetry in cerebral 
activity during tasks (divergent thinking, mental rotation tests, and verbal fluency tests) 
than males. When hemispheric integration is mandatory, men and women show similar 
asymmetry in EEG patterns (6-8, 10-11).
One study’s quantitative frequency analysis shows that women have significantly 
smaller absolute amplitudes (in µV) than men in the theta (20.6±9.5 versus 23.6±10.8), al-
pha1 (8-10Hz; 18.1±11.4 versus 22.9±15.8), alpha2 (10-13 Hz; 28.8±19.5 versus 34.9±19.7) and 
beta2 (20-25 Hz; 16.3±7.8 versus 18.5±7.6) bands, measured in the derivations from oc-
cipital to midline (see textbox). The absolute amplitudes of all frequency bands are also 
significantly smaller in women in the derivations from occipital to central: delta (12.0±7.8 
versus 16.7±8.8), theta (21.5±12.3 versus 28.2±15.6), alpha1 (18.9±13.8  versus 29.0±24.3), 
alpha2 (28.3±22.7 versus  38.3±22.7), beta1 (21.3±12.4 versus 26.4±15.1) and beta2 (16.0±9.3 
versus 20.1±10.6) (9). However, Ellis described higher amplitudes of beta-frequencies in 
the right occipital lobe in women (14). The clinical or physiological significance of these 
changes is not known. These gender differences may partly reflect functional anatomi-
cal differences between men and women. They may also be attributed to differences 
in hormonal patterns, a hypothesis that is supported by studies performed during the 
menstrual cycle.
eeG during the menstrual cycle
In eight studies investigating this subject there appears to be a correlation between 
the physiological hormonal fluctuations during the menstrual cycle and EEG findings: 
during the follicular phase, as estrogen levels are rising, there is a slower alpha-rhythm 
(alpha1-range) and an increase of power in the theta-frequency range (16-19). During the 
ovulatory phase, there is a lower power of alpha-rhythm in the EEG spectrum and higher 
interhemispheric correlations between frontal derivations (20-21). During the luteal 
phase, higher interhemispheric correlations between occipital derivations are seen (21). 
There is also a faster alpha-rhythm during the luteal phase; the mean frequency varies 
within the alpha2-range (10.3–14.1 Hz) measured by using Fast Fourier Transform analysis 
(16-18, 22). It has been suggested that the changes observed during the luteal phase are 
related to rising progesterone levels. Contreras et al. are the only investigators who have 
reported a decrease in alpha-frequency in the luteal phase compared to the follicular 
phase (23). Smaller cycle stage-dependent differences in the power of the theta- and 
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beta-bands have also been reported (16). During the premenstrual period, the power of 
delta, theta, and alpha1 (frequency of 7.5-9.5 Hz) has been reported to be higher. Theta-
activity has also been reported to be twice as common in EEGs obtained during the 
premenstrual period as in records obtained during other parts of the menstrual cycle 
(17). These results were not further quantified. During menstruation the power of the 
alpha2 (9.5-12.5 Hz), beta1 (12.5-17.5 Hz) and beta2 (17.5-30 Hz) have been reported to be 
higher (20-21).
Most studies of EEG changes during the menstrual cycle have not attempted to 
determine the clinical or physiological meaning of the reported differences. A lower 
alpha-frequency and increased theta-frequencies might reflect a slight decrease in brain 
function. However, in clinical practice, changes in alpha-frequency within one patient 
are usually regarded as clinically significant only if larger than 1 Hz, and the reported 
changes are not of this level.
eeG during normal pregnancy
Keunen investigated differences between EEG findings during the 3rd trimester of 
pregnancy and six months postpartum, and found no differences   in spectral EEG analy-
sis(24). No information on hormonal or lactation status was given. Poidevin (25) found 
EEG anomalies in 15% of the normotensive pregnant women, which is not significantly 
different from the incidence of EEG anomalies in the general population (14%) (26).
Chiang (27), Poidevin (25), and Sibai (28) used normotensive pregnant women as 
control group in their studies on hypertensive pregnancies. Chiang (27) described all 
EEGs as being within normal limits, based on visual assessment and Fourier analysis; no 
EEG anomalies were seen. However, alpha-rhythm frequencies were <8 Hz in 14%, and 
today <8 Hz is usually regarded as an abnormal frequency. Sibai (28) found in 15% of 
normotensive pregnant women diffuse slowing in the theta-range frequencies.
The clinical relevance of these EEG changes during normal pregnancy has never been 
studied. However, a tentative hypothesis is that the EEG changes are associated with 
some frequently experienced cognitive problems during pregnancy, such as forgetful-
ness and diminished mental alertness (29).
Search strategy
Searches were performed using MEDLINE and Embase databases with the following 
limits: language (English, German, French and Dutch) and human. All case-control stud-
ies executed between 1950 and January 2009 were considered eligible if they described 
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EEG results in adults in relation to hypertensive disorders in pregnancy. References of 
the retrieved articles were also screened for eligibility.
Search terms for EEG differences between normotensive and hypertensive pregnant 
women were searched using the search terms (“electroencephalography” or “EEG”) and 
(“pregnancy induced hypertension” or “preeclampsia”).
Excluded were articles discussing sleep EEGs and articles, which were not retrievable. 
Reviews, case reports and case series were only used for screening of the references. This 
review is written according to the QUORUM statement (30).
Search results
The search on hypertensive disease in pregnancy yielded 65 accessible articles (see 
figure). These potentially relevant articles were first screened by abstract. Based on 
reviewing the abstracts we excluded 15 articles, since the subject of the article was not 
to describe quantitative EEG alterations. After screening the remaining 50 articles for 
more detailed evaluation, 21 more articles were excluded. These articles were excluded 
because it became apparent that the article did not describe possible changes in EEG 
patterns during hypertensive disorders in pregnancy.  Since we only wanted to include 
articles describing case-control studies in our review, 21 more articles were exclude, in-
cluding six reviews (31-36), nine case reports (37-45) and six case series.(26, 46-50) These 
papers were used only for screening the references. 
The final search resulted in eight eligible case-control studies (25, 27-28, 51-55), which 
are summarized in table 1. These studies describe 782 pregnant women with hyper-
tensive disease. Cases were compared with normotensive (pregnant) women, men or 
epileptic patients.
eeG findings in pregnancy with essential hypertension
Slow waves (<8 Hz) were found in 15.3% of the EEGs obtained from women with essential 
hypertension, whereas 2.8% of the EEGs showed fast waves (>13 Hz). All of the EEGs 
(cases and controls) showed moderate amplitude; high voltages were only found in the 
hypertensive cases (27).
eeG findings in preeclampsia
Preeclamptic patients were included in seven of eight available studies (a total of 179 
patients, table 2). The incidence of EEG abnormalities in these women ranged from 5% 




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































The different types of anomalies found in preeclamptic patients were described as: 
diffuse slowing (n=4/26) (55), diffuse slowing in the form of theta/delta-waves (n=7/14) 
(28), focal slowing in the left posterior area (n=1/26) (55), focal spike discharges in the 
right hemisphere posterior area (n=1/26) (55), and pathological synchronizations and 
voltages in fast rhythms (52). The distinction between mild and severe preeclampsia 
was defined in only one report (Pritchard definition) (55); in another paper no defini-
tion was given (25). No significant differences were found between women defined as 
having mild versus severe preeclampsia (25, 55). Janzen (54) found normal EEGs in 95.2% 
(n=60/63) of preeclamptic patients. One of the women showed minor abnormalities, 
which were nearly within the normal range, and two other patients showed slowing. A 
higher incidence of “cerebral irritation” in all patients with a hypertensive pregnancy was 
described by Poidevin (25).
The EEGs recorded postpartum in preeclamptic patients by Colle were considered 
to be “normal” in 29% (n=4/14), “subnormal” (not further defined) in 43% (n=6/14) and 
“pathological” in 29% (n=4/14) of the patients. These pathological EEGs showed anoma-
lies in the occipital area recordings (51).













+ + + + NP + √
Sibai et al. 1984 + + + - + + √
Chiang et al. 
1964
- - + - NP NP x
ezes et al. 1960 - - - - NP NP x
Geiser-rauch et 
al. 1958
- + + - NP NP x
Colle et al. 1956 - + + - NP - x
Poidevin 1955 - + - - + NP x
Janzen et al. 
1952
- - - - NP NP x
+ sufficient    √  valid research according to current standards
- insufficient    x  non-valid research according to current standards
NP not performed
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eeG fi ndings in eclampsia
A total of 153 eclamptic patients were included in the eight available studies (25, 27-28, 
51-55). The incidence of abnormalities in these studies varied from 59% to 100%. On aver-
age, 81% of the EEGs of eclamptic women showed abnormalities.
Janzen et al. (54) stated that an EEG can be used to determine whether an intrapar-
tum seizure represents eclampsia or an epileptic seizure during labor. This group also 
reported that some EEG abnormalities, which are seen in eclamptic women one to three 
weeks postpartum, resemble those seen in an epileptic patient after a seizure. The EEG 
recordings obtained several years after eclampsia do not contain any abnormalities. 
Ezes et al. found no traces of diff use cerebral alterations in eclamptic patients, but they 
did fi nd acceleration peaks in the temporal area (52).
Of the 153 eclamptic patients included in these studies, 48% (n=30) with EEG abnor-
malities showed slowing (25, 28, 51, 55). Diff use slowing was described in seventeen 
women (28, 55); in one patient this was restricted to the right hemisphere (55). Focal 





Figure Articles suitable for reviewing 
Potentially relevant articles identified and screened for 
retrieval (n=65) 
Potentially appropriate articles for more detailed 
screening (n=50) 
) 
Articles excluded after screening abstracts (n=15) 
 
Articles excluded after more detailed screening (n=21) 
Potentially appropriate articles for reviewing (n=29) 
 
Articles with usable information by outcome (n=8) 
 
Articles excluded because they were reviews (n=6), 
case reports (n=9) and case-series (n=6) 
Figure 
Articles suitable for reviewing
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Spike discharges were found in ten eclamptic patients (28, 55). Five patients showed 
multifocal or diffuse spike discharges (55); one patient presented focal spike discharges 
in the left posterior area (55) and four patients showed paroxysmal spike activity (of 
which two had clinical seizures) (28). Thirteen of the eclamptic patients examined by 
Colle (51) showed “subnormal” (not further defined) EEGs; six of these patients had 
pathological EEGs containing bilateral abnormalities, occipital slowing (3-4 Hz) and 
paroxysmal anomalies.
Ezes (52) found diffuse or polymorphic delta-waves in eight patients and epileptic 
activity in the temporal area in four patients; these EEG anomalies were interpreted as 
prodromal for an eclamptic seizure. Chiang (27) examined the percentage EEG activity in 
the various frequency bands; 17.2% of the waves seen on the EEGs of eclamptic patients 
were slow waves (<8 Hz) and 1.0% of the observed waves were considered fast waves 
(>13 Hz).
Geiser-Rauch et al (53) performed provocation tests by means of hyperventilation and 
triple activation (a combination of Cardiazol, Narconumal and stroboscope) to eclamptic 
patients. In twelve of fourteen eclamptic patients, the EEGs were abnormal during the 
triple activation test; two showed a diffuse dysrhythmic reaction, ten showed bilateral 
low voltage, nine showed high slow paroxysmal waves, one showed a few bitemporal 
spikes and another showed arrhythmic spike waves without a clinical myoclonic attack. 
There were no significant EEG differences between eclamptic women and controls (both 
male and female students) at rest (53). However, during triple-activation a significant 
difference was seen: in the majority of eclamptic patients, there was latent brain stem 
sensitivity (bilateral synchronized waves).
eeG in preeclamptic versus eclamptic women
Osmanagaoglu found significantly (P<0,05) more abnormal EEGs in eclamptic patients 
than in either mild or severe preeclamptic patients (defined according to the ACOG crite-
ria) (55). However, Colle (51) found no differences in EEG patterns between preeclamptic 
and eclamptic patients.
Clinical symptoms and eeG abnormalities
In three studies, clinical findings, including mean arterial blood pressure in two studies, 
were documented in addition to EEG findings (27-28, 55). No correlations were found 
between mean arterial blood pressure and EEG abnormalities. However, Chiang (27) 
reported that clinical manifestations occurred more often in the patients with abnormal 
EEGs than in those with normal EEGs (40% (n=6/15) versus 24% (n=6/26).
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In the study performed by Osmanagaoglu (55) a significant (P<0,05) correlation was 
found between EEG findings and MRI (magnetic resonance imaging) studies; abnormal 
EEG findings were found in 87.5% (n=14) patients, both preeclamptic and eclamptic, who 
had MRI abnormalities. Three patients had only EEG abnormalities, and two patients had 
only MRI abnormalities.
Discussion
Since the majority of the studies we reviewed were published more than 20 years ago, 
we assessed the validity of the different studies according to current standards. The 
results of our validity assessment can be found in table 2. The most important items of 
the assessment will be described in the following paragraphs.
Six of the eight case-control studies were published before 1967 (25, 27, 51-54). The 
remaining two articles were published in 1984 (28) and 2005 (55). The first international 
definition of preeclampsia was adopted by the World Health Organization in 1985, and 
defined in the ACOG Technical Bulletin in 1986 (56). In their studies, Sibai et al. (28) used 
criteria defined in the obstetric handbook written by Pritchard (57), and Osmanagaoglu 
et al. (55) used ACOG criteria. Furthermore, several authors subdivided their groups of 
patients with hypertensive disorders of pregnancy into categories that do not corre-
spond with current definitions. For example, Chiang et al. (27) refers to “mild” eclamptic 
patients, and Poidevin (25) speaks of “moderate” preeclampsia and “moderate” eclampsia. 
The method by which an EEG is described and interpreted has changed over the 
years, and over time has been standardized. It is difficult to translate the descriptions 
of the EEGs in these older papers into current medical terminology. For example Colle 
et al. (51) and Janzen et al. (54) did not specify which definitions they used to divide the 
EEG recordings into “normal”, “subnormal” or “pathological“. Similarly, Iwanow (46) used 
terms such as “instable” and “slow acting”, but  did not clarify what was meant. The term 
‘dysrhythmia’ was used frequently (25-26, 51), but its use is currently discouraged in the 
official glossary of terms (58) since it does not specify the type of disturbance.
Several of the papers we reviewed had design flaws. For example, in three of the 
eight case-control studies we reviewed (27, 46, 53), more than one EEG per patient was 
included. These EEGs were evaluated as individual EEGs instead of as being representa-
tive of one patient, a policy that would artificially inflate the number of abnormal EEGs 
reported since, once EEG abnormalities occur in a patient, it is likely that subsequent 
EEGs in that patient will also be abnormal.
The reviewed articles indicated that there are minor differences in EEGs between men 
and non-pregnant women (6-15). Women show a more dynamic cerebral system, greater 
cerebral asymmetry during tasks, and more interhemispheric coherence. These gender 
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differences may be related to hormonal and anatomical differences. This explanation is 
supported by studies performed to evaluate the EEGs differences during the menstrual 
cycle. In menstruating women, there appears to be a correlation between estrogen 
and progesterone levels and alpha-waves in EEG recordings; slower alpha-waves oc-
cur during the follicular phase and faster alpha waves are apparent during the luteal 
phase. Unfortunately, there have been no proper studies that evaluated EEG differences 
between normotensive healthy pregnant women and non-pregnant women. In the 
report by Keunen et al. (24) the authors do not mention whether the puerperal women 
breastfed or not. Since hormonal status only becomes normal after breastfeeding has 
been discontinued, this may have influenced their results.
The observed EEG changes during the menstrual cycle and the EEG differences be-
tween the sexes seem not to be relevant to clinical practice. In the normal population, 
(mild) EEG anomalies can be found without associated clinically recognizable symptoms, 
and new EEG waveforms are still being identified (59). However, the EEG does appear 
to be slightly different in men compared to women and also appears to correlate with 
hormone levels. In future studies, the influence of confounding factors could be limited 
by using normotensive pregnant women as controls in clinical studies of EEG changes 
in hypertensive pregnancies.
In the studies we reviewed, diffuse or focal slow activity, most frequently localized in 
the occipital lobe, was the most common abnormal activity seen in EEGs made in both 
eclamptic and preeclamptic women, and there are no clear differences in these EEG find-
ings between mild and severe preeclamptic women. Spike discharges were described in 
the majority of eclamptic women. The review articles we evaluated (31-36) indicated that 
neither the severity of the preeclampsia nor the observed EEG alterations are predictive 
of the occurrence of eclampsia. The case-reports and case-series we reviewed (26, 37-50) 
provided no additional information.
Hypertensive encephalopathy is caused by the multifocal extravasation of fluid and 
proteins across the blood–brain barrier during ‘breakthrough’ of cerebral auto-regula-
tion. MRI has been useful in demonstrating the parieto-occipital high signal intensities 
involving the cortex and subcortical white matter, which are typical of preeclampsia, 
and can also determine whether there was permanent damage caused by ischemia. The 
reported MRI abnormalities included white and grey matter lesions indicating ischemia. 
The authors suggest that the combined use of EEG and MRI may help to determine the 
prognosis for these patients (55).
After reviewing the studies we selected, we conclude that the current value of these 
articles is limited. As mentioned in our introduction, electroencephalography is known 
to be a sensitive method to detect brain dysfunction due to hypoxia before clinical symp-
toms are present, and before ischemic conditions result in irreversible brain dysfunction. 
Therefore, it would be useful to perform more research on electroencephalography in 
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hypertensive gestational disease, according to current guidelines for EEG interpretation 
and using current medical terminology. This research should provide more detailed 
information concerning the type and localization of EEG anomalies associated with PE/
eclampsia.
In summary, our review shows that the EEG abnormalities that occur in association with 
in preeclampsia are reversible in the majority of cases. It is not yet clear whether these 
EEG abnormalities should be interpreted as a warning sign of deterioration of brain 
function due to PE/eclampsia. We hypothesize that EEGs may be used in the future to 
assess the severity of (pre-)eclampsia-associated encephalopathy, in order to determine 
when medical delivery or other medical interventions are needed.
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To compare electroencephalography (EEG) findings during pregnancy and postpartum 
in women with normotensive pregnancies and pregnancies complicated by hyperten-
sive disorders. Also the health related quality of life postpartum was related to these EEG 
findings.
Materials and Methods
An observational case-control study in a university hospital in the Netherlands. Twenty-
nine normotensive and 58 hypertensive pregnant women were included. EEG’s were 
recorded on several occasions during pregnancy and 6-8 weeks postpartum. Postpar-
tum, the women filled out health related quality of life questionnaires. Main outcome 
measures were qualitative and quantitative assessments on EEG, multidimensional 
fatigue inventory, Short Form (36) Health Survey and EuroQoL visual analogue scale.
results
In women with severe preeclampsia significantly lower alpha peak frequency, more 
delta and theta activity bilaterally and a higher EEG Sum Score were seen. Postpartum, 
these women showed impaired mental health, mental fatigue and social functioning, 
which could not be related to the EEG findings.
Conclusions 
Severe preeclamptic patients show more EEG abnormalities and have impaired mental 
wellbeing postpartum, but these findings are not correlated.
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Preeclampsia (PE) is a multi-organ disease of unknown cause unique to human pregnancy. 
PE affects 1-7% of all pregnancies. Neurologic complications due to hypertensive disease 
in pregnancy are among the leading causes of maternal morbidity and mortality (1).
Currently we do not have a tool to monitor disturbances in the brain function in order 
to prevent complications. Electroencephalography (EEG) is known to be a sensitive 
method to detect brain dysfunction. EEG changes can be found before clinical symp-
toms are present and before ischemic conditions may result in irreversible brain dys-
function (2). We have published a systematic review on EEG in hypertensive pregnancy 
and believe there is need for new data, using the current terminology and definitions (3). 
The objective of this review was to evaluate the available medical literature concerning 
the EEG during hypertensive disorders of pregnancy. Abnormal EEG findings were ob-
served in the majority of the women with PE/eclampsia, consisting of slow waves most 
frequently localized in the occipital lobe, as well as spike discharges. The EEG abnormali-
ties in PE/eclampsia were reversible in the majority of the cases. We concluded that the 
described abnormalities might be interpreted as a warning sign of deterioration of brain 
function in PE/eclampsia. However, we advised some caution regarding this conclusion, 
because most of the retrieved articles were published in the 1950s and 1960s, and were 
not consistent with current clinical guidelines or medical terminology.
Somatic symptoms of PE, such as hypertension and proteinuria, generally disappear 
rapidly after delivery. However, formerly preeclamptic women more often complain 
of mental health problems as compared to women after uncomplicated pregnancies 
(4). These complaints may persist and can interfere with quality of life. Therefore, these 
complaints must not be underestimated.
We hypothesized that severe PE influences the brain through hypoxia and edema. This 
could therefore have an effect on brain function, which does not disappear immediately 
after delivery. This altered brain function could influence physical and mental health. In 
this study we describe EEG during the course of normotensive pregnancies as compared 
to hypertensive pregnancies and we relate EEG findings to health related quality of life 
(HRQoL) 6 to 8 weeks postpartum.
Materials and Methods
In this prospective longitudinal case-control study normotensive healthy pregnant 
women, serving as a control group, and patients with chronic hypertension (CH), preg-
nancy induced hypertension (PIH), mild preeclampsia (mild PE) and severe preeclampsia 
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(severe PE) underwent EEG testing during their pregnancies and postpartum. Postpar-
tum all women filled out HRQoL questionnaires.
The Medical Ethics Committee Erasmus MC of Rotterdam approved the study protocol 
(MEC-2005-142). After obtaining written informed consent, participants were included in 
this study from October 2005 till October 2008.
Normotensive women, women with CH and women with PIH were consecutively re-
cruited in the outpatient clinic. Patients with mild PE and severe PE were recruited after 
admission at the department of obstetrics of the Erasmus MC.  Normotensive women and 
those with CH were examined at the following gestational ages: 12-14 weeks, 26-28 weeks, 
32-34 weeks and 36-40 weeks. Women who developed PIH were included when diagnosed 
and examined at the same time points.  Preeclamptic patients were consecutively included 
at admission and, if possible, measured weekly until delivery. Severely preeclamptic pa-
tients underwent an EEG after initial stabilization with antihypertensive medication and, 
if necessary, magnesium sulphate. Finally, all participants were re-examined 6-8 weeks 
postpartum. All participants spoke Dutch fluently. Exclusion criteria were: use of medica-
tion other than antihypertensive medication and/or magnesium sulphate, gestational 
diabetes, diabetes mellitus, pre-existing neurological disorders and psychiatric illnesses.
According to the criteria of the International Society for the Study of Hypertension in 
Pregnancy (ISSHP), PIH was defined as de novo hypertension after 20 weeks of gestation 
in absence of proteinuria and PE as hypertension in the presence of de novo proteinuria 
(5). Severe PE was diagnosed if in addition one or more of the following criteria were 
present: a systolic blood pressure of 160 mmHg or higher and/or a diastolic blood pres-
sure of 110 mmHg or higher; proteinuria of 5 gram or more in a 24-hour urine specimen 
or dipstick urinalysis of 3+ or greater in two random urine samples collected at least 4 
hours apart; oliguria of less than 500 mL in 24 hours; cerebral or visual disturbances; 
pulmonary oedema or cyanosis; epigastric or right upper-quadrant pain; impaired liver 
function; thrombocytopenia; foetal growth restriction (6). All patients who did not meet 
these criteria for severe PE were diagnosed as having mild PE.
Ethnicity and the level of education were obtained from the questionnaires. Level of 
education was assessed by the highest completed education. It was divided into three cat-
egories: low (primary school, lower vocational training and intermediate general school), 
mid (intermediate and higher vocational training) and high (university degree) (7).
The EEG recordings were made in accordance with the 10-20 International System 
of Electrode Placement. Electrode impedances were less than 5  kΩ (8). The registra-
tions were recorded during wake. EEG registrations were blinded reviewed by one of 
the authors (GHV) using referential, source, and bipolar montages. In addition, the 
dominant occipital EEG activity (alpha rhythm) was quantitatively assessed using fast 
Fourier Transformation (FFT) and documented for both sides of the brain as alpha peak 
frequency (APF) (samples with epoch length 10 s; ≥ 10 epochs averaged). The EEG alpha 
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rhythm is electrical activity with an occipital maximum that can be seen in relaxed per-
sons with eyes closed. In a healthy adult the normal frequency is above 8.5 Hz. Reference 
values of the APF are not gender specific and show a mean of 10.02 Hz (SD 0.9) (9). 
The visual assessment scored presence, type, amount and localization of intermittent 
slow activity, continuous slow activity, sharp waves and focal epileptiform activity. Delta 
waves are slow frequency waves present in deep sleep. Theta waves are slow frequency 
waves present just before sleep. We subdivide interictal findings in sharp waves and 
focal epileptiform activity. Sharp waves are associated with epileptic activity, but can 
also been found in people who never develop epileptic seizures. Focal epileptic activity 
always contains complexes with spikes and slow waves. Definitions of terms in interictal 
findings are published in Appendix S4 in Epilepsia (10). These activities were combined 
in the EEG Sum Score (Figure 1). This score was adapted from the Grand Total EEG score, 
which was published by Jonkman ranging from score 0 for a completely normal EEG to 
17 for the most severely abnormal EEG (11, 12).
 
 Fig 1. EEG Sum Score a  
 
Alpha rhythm 
1. Alpha peak frequency (APF) 
0 = APF>9 Hz or APF is not measurable  
1 = APF > 8 Hz and </= 9 Hz 
2 = APF </= 8 Hz 
Intermittent slow activity (theta or delta waves) 
2. Presence 
0 = none 
1 = 1-10 times 
2 = >10 times 
3. Type 
0 = theta and/or sporadic delta 
1 = theta and delta 
2 = mostly delta 
Continuous slow activity (theta of delta activity) 
4. Presence and type 
0 = none 
3 = theta and/or sporadic delta 
5 = theta and delta or if mostly delta) 
Sharp waves 
5. Presence 
0 = none 
1 = 1-10 times 
2 = >10 times 
Focal epileptiform activity ((poly)spikes, (poly)spike-and-slow-wave complex) 
6. Presence 
0 = none 
2 = 1-4  
4 = >/=5 times  
a EEG Sum Score is the sum of items 1 to 6, ranging 0-17 points Figure 1. eeG Sum Score a
a EEG Sum Score is the sum of items 1 to 6, ranging 0-17 points
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HRQoL is a multidimensional concept with physical, psychological and social domains. 
The combination of the domain-specific Multidimensional Fatigue Inventory (MFI) for 
fatigue and two generic measures of own health, Short Form (36) Health Survey (SF-36) 
and the EuroQoL visual analogue scale (EQ-VAS) classification, show good psychometric 
performance, are internationally standardized and widely used in the postpartum pe-
riod (13-15).
For statistical analysis SPSS was used, version 20.0 (SPSS Inc. Chicago, Illinois, US). 
P-values < 0.05 were considered significant. The differences between the study groups 
on baseline characteristics and HRQoL were analysed using ANOVA, Pearson Chi-Square 
tests and Fisher’s exact tests when applicable. ANCOVA was used to study the associa-
tion of HRQoL with covariates. The correlation between the EEG items and HRQoL items 
was computed using the Spearman’s correlation coefficient. To perform this analysis for 
the APF during pregnancy we used the area under the longitudinal trajectory of each 
patient as a summary of her APF profile (i.e., average APF during pregnancy). Postpartum 
we used the postpartum value of the APF. To account for the correlation in the repeated 
measurements of each patient during pregnancy, a repeated measures analysis has been 
performed to analyse each parameter using linear mixed effects models. Accordingly, 
for the Sum Score, a Poisson mixed effects regression was utilized. To allow for possible 
nonlinearities in the parameters’ evolution in time we used regression splines of time in 
the specification of the fixed and random effects of the model, when supported from the 
data. The repeated measures analysis has been performed in the R statistical software 
(version 2.15.1) using package nlme (version 3.1-104). The models’ assumptions were 
checked using residuals plots. 
results
A total of 103 pregnant women were initially included. Fifteen patients withdraw their 
participation after the first examination and one patient miscarried, remaining 87 study 
subjects: 29 normotensive women, nine CH, six PIH, 14 mild PE and 29 severe PE patients. 
Two of the previously normotensive pregnant patients developed PE (one mild PE 
and one severe PE) and one other patient developed PIH. They were categorized and 
analysed in the group with their contracted hypertensive disease. A total of 85 women 
received the HRQoL questionnaires, 71 questionnaires were returned. In 66 of those 71 
cases an EEG was made postpartum.
Table 1 shows the patient characteristics. As expected, there are significant differences 
between the five groups in blood pressure, gestational age, mode of delivery and parity. 
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Age (years) a,b 32.0 (5.3) 32.5 (3.2) 32.0 (5.1) 32.2 (4.5) 30.3 (6.5) .687
Systolic blood 
pressure (mmHg) a,b
113 (12.1)*†‡ 122 (16.5)*† 136 (16.9) 136 (10.2) 145 (16.8) .000#
Diastolic blood 
pressure (mmHg) a,b
65 (7.1)*†‡§ 78 (8.0)*†‡ 87 (9.8) 87 (4.8) 92 (10.2) .000#
Gestational age al 
delivery (days) a,b
277(11.5)*† 273 (12.3)* 266 (15.0)* 257 (19.4)* 224 (29.3) .000#
Level of education c,d .004#
Low 10.7 12.5 50 0 0
Mid 60.7 75 16.7 92.9 85.2
High 28.6 12.5 33.3 7.1 14.8
Ethnicity c,d .763
Caucasian 82.8 77.8 66.7 78.6 69.0
Non-Caucasian 17.2 22.2 33.3 21.4 31
Mode of delivery c,d .000#
Vaginal 82.8 100 83.3 50.0 20.7
Elective cesarean 13.8 0 16.7 21.4 75.9
Emergency cesarean 3.4 0 0 28.6 3.4
Parity c,d .027#
Nulliparous 51.7 11.1 50.0 50 62.1
Para-1 37.9 88.9 16.7 42.9 27.6
Para-2 3.4 0 0 7.1 20.3
Para-3 6.9 0 33.3 0 0
NICU admission 
(days) f
0 (0-2) 0 (0-5) 0 (0-0) 2.5 (0-35) 13 (0-92) .000#,e
Perinatal death g 0 0 0 0 1
a Mean (SD)b One way ANOVA was used 
c Number (%)
d Chi-Square test (Fisher’s exact) was used
e Kruskal-Wallis test was used
g Median (range)
f Total
* p≤ 0.05 vs. sPE, †p≤ 0.05 vs. mPE, ‡p≤ 0.05 vs. PIH, §p≤ 0.05 vs. CH
# p≤ 0.05
Abbreviations: NICU, Neonatal Intensive Care Unit; sPE, severe preeclampsia; mPE, mild preeclampsia; PIH, 
pregnancy induced hypertension; CH, Chronic Hypertension
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Figure 2 presents APF during pregnancy and postpartum for each group. In 5 normoten-
sive women, during one or more of the measurements, no alpha rhythm was detected and 
therefore APF could not be determined. In the groups with CH, PIH, mild PE and severe PE 
there were respectively 1, 0, 2 and 2 women where the APF could not be determined dur-
ing one or more of the measurements. These measurements were excluded for APF analy-
sis. The APF was measured occipital on the left and right side at every time point of the 
measurements. There was no significant left-right difference in APF in the normotensive 
group (Intraclass Correlation Coefficient of > 0.930 at all 5 time points). Therefore we used 
the mean of the right and left APF in further analysis. There was a strong intra-individual 
correlation between all subsequent time points (all pair wise r> 0.864, p< 0.001).
Figure 2. Alpha Peak Frequency during pregnancy and post partum a
a The repeated measures analysis has been performed using linear mixed effects models. Data are pre-
sented in mean and 95% Confidence Interval
Abbreviations: Hz, Hertz; pp, post partum, HELLP, Hemolysis Elevated Liver enzymes Low Platelets
We found no evidence of a time effect (Likelihood Ratio Test (LRT) = 13.5, degrees of free-
dom (d.f.) = 15, p = 0.560), meaning that the APF remained constant during pregnancy. 
However, there was an overall statistical difference between the five groups (LRT = 38.3, d.f. 
= 20, p= 0.008), but there was no indication that this difference attributed to differences in 
the longitudinal evolutions (LRT = 8.2, d.f. = 12, p= 0.770). The severe PE group differed sig-
nificantly from the other groups (versus normal: p=0.000, versus CH: p=0.058, versus PIH: 
p=0.058, versus mild PE: p=0.007). The APF was on average 0.6 Hz higher postpartum than 
it was during pregnancy (p= 0.001) in   all groups, but there were no significant differences 
between this increase and the absolute values postpartum (LRT = 2.6, d.f. = 4, p= 0.629).
There is no evidence of association between the mean APF and systolic blood pressure 
(p= 0.692), or between APF and diastolic blood pressure (p= 0.229). Repeated measures 
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ANOVA did not show a significant age-effect (p=0.191) or an effect of parity (p=0.500) on 
the APF values.
The amount, type and localization of EEG abnormalities are shown in Table 2. Per per-
son more than one abnormality can be found. More intermittent slow and continuous 
slow activity was seen in the mild PE and severe PE groups, especially bilateral delta and 
theta activity fronto-temporal. In a few cases of severe PE sharp waves were seen and in 
one case epileptiform activity was seen postpartum. In the severe PE group abnormali-
ties were more frequently. Because we did not find unilateral continuous slow activity 
and unilateral epileptiform activity, these activities were not included in Table 2.
Figure 3 presents the EEG Sum Score during pregnancy and postpartum for each 
group. We found no evidence of a time effect (LRT = 3.8, d.f. = 5, p= 0.581), meaning that 
the Sum Score also remained constant during pregnancy. There was an overall statisti-
cally significant difference between the five groups (LRT = 40.3, d.f. = 12, p<0.0001), but 
there was no indication that this difference attributed to the differences in the longitu-
dinal evolutions (LRT = 2.8, d.f. = 4, p= 0.594). The severe PE group differed significantly 
from the other groups (versus normal: p=0.000, versus CH: p=0.027, versus PIH: p=0.005, 
versus mild PE: p=0.043). The mean Sum Score was on average 0.213 lower postpartum 
than it was during pregnancy and was not statistically different between the groups 
(p= 0.360). We did not find statistical differences between the study groups in the post-
partum measurement of the EEG Sum Score (LRT = 3.2, d.f. = 4, p= 0.525). Furthermore, 
we found no evidence of an association between the EEG Sum Score and systolic blood 
pressure (p= 0.624) or diastolic blood pressure (p= 0.445).
Figure 3. Sum Score during pregnancy and post partum a
a The repeated measures analysis has been performed using linear mixed effects models. Data are pre-
sented in mean and 95% Confidence Interval


















































































































































































































































































































































































































































































































































































































































































































































































































































































































In our study one woman in the normotensive group developed severe PE. Her individual 
APF values were plotted in Figure 4. She developed severe PE in the 38th week of gestation. 
This woman had a relatively low APF during her entire pregnancy and postpartum. The vi-
sual assessment of her EEG showed no anomalies, except at a gestational age of 35 weeks, 
as it showed focal bilateral intermittent theta and sporadic delta activity, which can be 
classified as mild and non-specific abnormalities. The other two normotensive women, 
who developed to PIH and mild PE, had APF values within the ranges of these groups.
Figure 4. Course of Alpha Peak Frequency in a patient who developed Severe Preeclampsia a,b,c
a Data of patient is presented in red dots
b Black line and dotted lines are data of Severe Preeclampsia + HELLP, as presented in Figure 2
c Blue line and dotted lines are data of Normotensive women, as presented in Figure 2
d Red line: patient developed Severe Preeclampsia
Abbreviations: Hz, Hertz; pp, post partum; HELLP, Hemolysis Elevated Liver Enzymes Low Platelets
Table 3 shows the results of the HRQoL questionnaires (EQ-VAS, MFI and SF-36). Items 
reflecting mental health and fatigue, and social functioning were statistically different 
between the study groups. The patients with severe PE showed the worst HRQoL scores.
The internal consistency of the SF-36 and the MFI multi-item scales was determined 
with Cronbach’s alpha-coefficient. The item General Health in the SF-36 had a Cronbach’s 
alpha-coefficient of 0.51, due to the fact that the answers to some of the questions 
were given inconsistently. The other items had a Cronbach’s alpha-coefficient of 0.70 or 
higher. Based on this, the internal consistency of the SF-36 and the MFI multi-item scales 
was considered sufficient for the purpose of group comparisons.
We investigated the association between the APF and EEG Sum Score values prior to 
delivery and postpartum with the HRQoL items measured postpartum. As a summary of the 
mean AFP during the course of pregnancy we used the area under the longitudinal trajec-
tory of each patient. As a summary of the EEG Sum Score during the course of pregnancy we 
used the area under the longitudinal trajectory of each patient. The Spearman correlation 
coefficients between the summaries of the longitudinal trajectories and the postpartum 
HRQoL items, the APF values and EEG Sum Scores did not show any significant correlation.
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All items in Table 3 were tested for confounders. Differences between the study groups 
remained significant for the items mental fatigue (p=0.003), mental sum score (p=0.020), 
social functioning (p=0.022) and mental health (p=0.001) correcting for maternal age, 
ethnicity, level of education, parity, gestational age and mode of delivery, and admission 
of the neonate to the neonatal intensive care unit (NICU).
Discussion
This is the first longitudinal study on both quantitative and qualitative EEG findings in 
normotensive pregnant women and women with hypertensive disorders of pregnancy. 
In women with severe PE significantly lower APF, more bilateral delta and theta activity 
and a higher EEG Sum Scores were seen. These findings recovered postpartum. Postpar-
tum, these women showed more impaired mental health, mental fatigue and decreased 
social functioning. These HRQoL outcomes, however, were not correlated with the 
above-mentioned EEG changes, as we hypothesized. 
Our study shows that the APF remains constant during the course of pregnancy in 
all groups. In patients with severe PE the APF was significantly lower during the clinical 
phase of the disease. The APF was already altered during the non-clinical phase in the 
only normotensive patient that developed severe PE (Figure 4), but postpartum the APF 
remained low. The latter may be explained by a pre-existing phenomenon or by slow 
recovery from severe PE. Postpartum the differences in APF between the study groups 
disappeared, reflecting recovery of this aspect of brain function in severe PE patients. In 
only three patients with severe PE we recorded APF lower than 8.5 Hz during pregnancy. 
Postpartum, their APF measurements returned within the normal range. Low values in 
APF have also been found in patients with psychiatric disorders like depression, chronic 
fatigue syndrome and burnout.(16) A decrease in APF is related to decreased perfor-
mance on memory tasks (17). In 2008 we published a study that showed that memory 
was impaired in formerly severe preeclamptic women (18). 
We were not able to stratify for early (n=5) and late onset severe PE (n=24). In the 
subgroup of patients with early onset severe PE, APF was 0.8 Hz lower. However, this 
was not significant different, probably because of small sample size, but could be indica-
tive for worse clinical disease. There were no significant differences in APF for the other 
hypertensive groups. The confidence intervals for the CH en PIH groups are wide (Figure 
2), probably caused by the small sample size. We could not identify alpha rhythm during 
one or more of the sessions in 10 women (11.5%). In other studies the APF is poorly visual-
ized in up to 25% of the general population due to inability to relax (19).
The EEG abnormalities found in normotensive pregnancies were mild, showing inter-
mittent slow mostly theta activity and occasionally sharp waves, predominantly in the 
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frontal and temporal areas (Table 2). Focal epileptiform activity was not seen in the nor-
motensive group. In women with abnormalities these were both seen during pregnancy 
and postpartum. In severe PE multifocal and bilateral intermittent and continuous slow 
activity was seen more frequently. Postpartum the decrease in continuous slow activity 
can be regarded as an improvement of the supposed hypertensive encephalopathy 
in these patients, although there was some increase in sharp waves and epileptiform 
activity. We can only speculate whether these abnormalities were already present before 
pregnancy, pregnancy induced, or will remain permanently. The EEG abnormalities 
found in this study might be reflected in cognitive failures like memory loss, as was 
earlier described (18, 20). Persistent cerebral anomalies were described in a MRI study 
in both formerly eclamptic and preeclamptic women with neurological symptoms and 
may actually reflect permanent brain ischemia (21). In our study EEG anomalies subsided 
or disappeared 6-8 weeks postpartum. EEG is in our opinion a more precise and sensitive 
instrument to detect functional brain damage than MRI.
In order to evaluate the visually assessed EEG in combination with the APF we summa-
rized the EEG characteristics in the EEG Sum Score. This score did not significantly vary 
during the course of pregnancy and postpartum. Even the individual scores remained 
constant. This could either mean that the neuronal activity in the brain is not normalized 
completely 6 to 8 weeks postpartum, or is not influenced by pregnancy. Combining this 
finding with the results on APF, the first opinion is most likely.
We found in one third of the normotensive women (n= 9) that the EEG Sum Score 
was more than 0 during the first measurement, due to minor abnormalities in the visual 
assessment.  Literature on EEG in normotensive pregnancies is scarce and relatively 
old (3). Two relatively small studies report EEG abnormalities in 15% of normotensive 
pregnant women (22, 23). Volume shifts, blood pressure and hormonal changes could 
be responsible. It’s tempting to speculate that these minor EEG abnormalities reflect the 
often reported cognitive disturbances like mental slowness and forgetfulness during 
uneventful pregnancies.
The number of studies on the long term effects of PE is increasing (20, 24-26). As 
somatic symptoms merely disappear after delivery, many women continue to complain 
of cognitive disturbances. We showed that the severe PE group has the worst HRQoL 
scores, significantly in items reflecting mental fatigue, mental health and social func-
tioning. These results are in line with other studies. Postpartum maternal morbidity after 
preeclamptic pregnancy may be directly related to the severity (27, 28). The psychosocial 
impact, admittance to an intensive care unit and health of the newborn may also affect 
women’s mental health (24, 29, 30).
Lower APF and visual EEG abnormalities resulting in higher EEG Sum Score are mostly 
seen in the severe PE group during pregnancy. These abnormalities did not correlate 
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with worse HRQoL outcomes postpartum. Probably other, unknown, factors of the 
disease not evident in the EEG could have had more impact on HRQoL postpartum.
The strength of our study is the presence of longitudinal data on both quantitative 
and qualitative EEG findings during normotensive and hypertensive pregnancies, and 
postpartum. Another strength is that we quantified EEG data in APF and introduced the 
EEG Sum Score.
Due to the low incidence of preeclampsia a very large amount of normotensive 
women should be included to be able to perform EEGs systematically prior to the onset 
of PE. This can be seen as a limitation of our study.  We chose to compare EEGs in a group 
of normotensive pregnant women to women with hypertensive disorders of pregnancy. 
Unfortunately, we included relatively small sample sizes in the groups of women with 
CH en PIH.
Our data can be used as reference values for EEGs performed during pregnancy and in 
the postpartum period. Preconception and late postpartum measurements are lacking 
which could be considered as a limitation, but logistically this was not possible.
This study adds knowledge of the reduced wellbeing that might be helpful in provid-
ing care for women after severe PE, which has consequences for their postpartum return 
to normal life and work. 
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Preeclampsia is a severe hypertensive disorder of pregnancy which may lead to brain 
complications such as eclampsia. Visual symptoms are present in ~ 25% of preeclamptic 
women suggesting the visual cortex to be altered during preeclampsia. Visual evoked 
potentials (VEPs) measure the functional neuronal integrity of the visual pathway from 
retina to the occipital cortex of the brain. The objective of this study was to compare 
neurophysiological changes in women with hypertensive disorders of pregnancy using 
VEPs. We hypothesized that women with hypertensive disorders of pregnancy develop 
abnormal latency and amplitude of visual evoked potentials as compared to normoten-
sive pregnant women.
Methods
We performed a prospective observational study in 29 normotensive pregnant women, 
8 women with chronic hypertension, 9 with pregnancy- induced hypertension, 15 with 
mild preeclampsia and 33 with severe preeclampsia. VEP measurements were made at 
four different time points of gestation (12-14 weeks, 26-28 weeks, 32-34 weeks, 36-40 
weeks) and 6-8 weeks postpartum.
results
We defined reference values for normotensive pregnant women. Normotensive preg-
nant women had a shorter latency during pregnancy compared to their postpartum 
value (P = 0.005). Women with severe preeclampsia had a prolonged latency of VEPs 
compared to normotensive pregnant women (P = 0.006), a difference that disappeared 
postpartum.
Conclusions 
Our study showed neurophysiological adaptation to pregnancy of the visual cortex in 
normotensive pregnant women, that seemed to be absent in women with hypertensive 
disorders of pregnancy.
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About 2-8% of all pregnancies are complicated by preeclampsia (PE), a major cause 
of morbidity and mortality in both mother and fetus (1, 2). The maternal brain can be 
involved in PE and lead to severe complications such as eclampsia (3, 4). Brain complica-
tions may be the result of a disturbed autoregulatory response of the brain to increased 
blood pressure and endothelial cell dysfunction, which clinically presents as posterior 
reversible encephalopathy syndrome (PRES) (5). An elevated cerebral perfusion pressure 
may also predispose to cerebrovascular complications in PE (6). In addition, abnormali-
ties on the electroencephalogram (EEG) are observed during this disorder (4, 7). In fact, 
experimental PE is associated with neuroinflammation and significantly decreased 
seizure threshold (8). However, clinical evaluation of brain excitability during PE is not 
routinely performed that may help predict and/or prevent eclampsia in women with PE.
Visual symptoms are present in approximately 25% of pre-eclamptic women. The 
exact pathophysiology of this has not been elucidated yet. The origin of these visual 
disturbances may involve adaptation of the ophthalmic pathway (9). Normal pregnancy 
is associated with neurophysiological adaptations of the brain, including decreased 
inhibitory gamma-aminobutyric acid type A (GABAA) receptor subunit expression in the 
cerebral cortex that lowers seizure threshold (10). In addition, a previous study showed 
visual evoked potential (VEP) latencies to decrease as gestation advances, suggesting 
adaptation of the visual cortex during pregnancy as well (11). However, the functional 
status of the visual cortex during PE or hypertension in pregnancy that could lead to 
visual symptoms has not been investigated.
The objective of this study was to compare neurophysiological function of the visual 
cortex using VEPs of normotensive pregnant women to women with hypertensive dis-
orders of pregnancy. We studied women with mild and severe PE, women with chronic 
hypertension (CH) and pregnancy-induced hypertension (PIH). VEPs measure the func-
tional integrity of the visual pathway from retina to the occipital cortex of the brain 
(12). The most clinically useful measurements are the latency and amplitude of the P100 
component. Abnormal VEPs may present as changes in latency, amplitude, topography 
and waveform, of which latency prolongation is the most reliable parameter (13). Our 
hypothesis was that women with hypertensive disorders of pregnancy have an abnor-
mal VEP latency and amplitude compared to normotensive pregnant women. In order 




From October 2005 till July 2008 a prospective observational study was performed at 
the Department of Obstetrics and Gynecology of the Erasmus MC University Medi-
cal Center in the Netherlands. Approval for the study was given by the Erasmus MC, 
University Medical Centre Research Ethics Board (MEC 2005-142). All women provided 
written informed consent before participation. Normotensive and chronically hyperten-
sive pregnant women were recruited at the outpatient clinic at a gestational age of 12 
weeks. They underwent clinical and neurophysiological measurements at five different 
time points: at a gestational age of 12-14 weeks, 26-28 weeks, 32-34 weeks, 36-40 weeks 
and 6-8 weeks postpartum. Women with PIH or PE were recruited at the moment of 
diagnosis and investigated during remaining pregnancy and 6-8 weeks postpartum.
PE was defined as a systolic blood pressure of ≥140 mmHg or diastolic blood pressure 
of ≥ 90 mmHg on at least two occasions 4 hours apart after 20 weeks of gestation or 
post-partum with proteinuria (≥ 300 mg/24 hours or protein/creatinine ratio ≥ 0.3 mg). 
Severe PE was defined as systolic blood pressure ≥160 mmHg or diastolic blood pres-
sure ≥ 110 mmHg or PE with a multisystem complication (thrombocytopenia, impaired 
liver function, renal insufficiency, pulmonary edema, cerebral disturbances, visual 
impairment) (14). Women with PE were treated with antihypertensive medication before 
the measurements. Women with gestational diabetes, diabetes mellitus, neurological 
disorders, muscular diseases and psychiatric disorders were excluded.
VEPs were measured using a Viking 4 device (Natus Neurology. Middleton, USA). We 
used pattern reversal stimulated VEPs because these responses show less individual 
variation and are more sensitive for lesions in the visual tract compared to flash VEP (12). 
The VEP recordings were made in accordance with the 10-20 International System of 
Electrode Placement (15). Briefly, the participant was instructed to focus on one central 
point in the pattern, while one eye was covered (Figure 1). The distance from eye to 
screen was 86 centimeters. The visual system was stimulated by a checkerboard pat-
tern, which changes every half-second. The blocks were square, with a size of 1.5 cm. The 
total amount of illumination stayed the same. The time period of the analysis was 250 
milliseconds following the onset of the visual stimulus. An average of at least 100 stimuli 
was produced and registered after two reproducible curves.  All women had normal 
visual abilities (with or without correction) and normal electroretinogram, tested during 
the visit.
All data were analyzed using the statistical software package SPSS 21 (SPSS, Chicago, 
IL, USA). To test the clinical characteristics of the five study groups we used analysis of 
variance (ANOVA) and post hoc Dunnett t-test for pairwise comparisons or Kruskall-Wal-
lis testing and post hoc Mann-Whitney testing for skewed data. Categorical data were 
compared using Chi-square/Fischer’s exact testing. Comparisons of the VEP latency and 
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amplitude were made using an analysis of covariance (ANCOVA) model, adjusted for 
gestational age at measurement. The amplitude values were log transformed before 
testing because they were not normally distributed. VEP latency and amplitude were 
measured of the left and right eye of every woman (except for three women where only 
one side could be measured). Paired testing of the results of the VEP between both eyes 
showed no significant difference between the eyes. Consequently, the values used for 
the statistic model were randomly chosen. The reference value of VEP latency was deter-
mined by mean plus two standard deviations (latency upper limit). For VEP amplitude, 
which was not normally distributed, the 5th percentile was used as reference value (am-
plitude lower limit). A paired t-test was used for the comparison of the measurements 
during pregnancy with postpartum.




Figure 1. Image of a woman during VeP registration
Positions of the electrodes according to International 10-20 system: Oz (mid-occipital), O1 (occipital left 
hemisphere), O2 (occipital right hemisphere), T3 (temporal left hemisphere), T4 (temporal right hemi-
sphere). Reference electrode Fz (mid-frontal). Earth electrode: Cz (mid-central).
results
A total of 94 pregnant women participated in this study and underwent at least one 
VEP measurement. Twenty-nine women were normotensive, 8 had CH, 9 developed PIH, 
15 mild PE and 33 severe PE. Clinical characteristics are shown in Table 1. Preconception 
BMI of the normotensive controls and women with severe PE was lower than the BMI of 
women with mild PE. As expected, gestational age at delivery was lower in the group 
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with severe PE compared to all other groups. Birth weight percentile was more often 
under the <10th percentile in mild and severe PE compared to normotensive controls. 
Multiple visual complaints were present in 18.8% of patients with severe PE and in 
0% of normotensive pregnancies (table 1). We scored the following visual complaints: 
flashes, scotomas, blurry vision, blindness and disturbed color vision. Participants, who 
had more than one visual complaint, always reported flashes. Only severe PE patients 
reported more than two visual complaints.













Maternal age, years, 
mean (±SD) 
32.0 (±5.3) 32.8 (±3.4) 32.7 (±5.6) 31.2 (±4.9) 30.0 (±6.7) 0.509
Ethnicity 0.819
Caucasian, n (%) 24 (82.8) 6 (75.0) 6 (66.7) 10 (66.7) 23 (69.7)
Other, n (%) 5 (17.2) 2 (25.0) 3 (33.3) 5 (33.3) 9 (27.3)
Missing, n (%) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (3.0)
Current pregnancy
Nulliparous, n (%) 15 (51.7) 0 (0.0) 5 (55.6) 8 (53.3) 20 (60.6) c 0.033
Preconception BMI, 














8 (27.6) 0 (0.0) 2 (22.2) 1 (6.7) 5 (15.2) 0.292
Preconception 
alcohol, n (%)




0 (0.0) 1 (12.5) 1 (11.1) 1 (6.7) 1 (3.0) 0.190
PE in previous 
pregnancy, n (%)
0 (0.0) c 7 (87.5) 1 (11.1) 3 (20.0) 5 (15.2) 0.004
Refraction correction, 
n (%)




0 (0%) 2 (25%) 1 (12.5%) 0 (0%) 6 (18.8%) 0.020
63





In Figure 2 individual values of VEP latency and amplitude throughout normotensive 
pregnancy is shown. There were no significant differences in mean latency and mean 
log transformed amplitude between the five groups by using ANCOVA models, adjusted 
for gestational age at measurement. Because only a limited number of women with 
hypertensive disorders were measured in the first and second trimester (only 9 women 
attended the first two visits) we were not able to analyze the data of these measure-
ments longitudinally.













































 <10th percentile, 
n (%)
0 (0.0) a b 1 (12.5) 0 (0.0) 4 (26.7) 14 (42.4)
 10th-90th percentile, 
n (%)
22 (75.9) 6 (75.0) 8 (88.9) 11 (73.3) 19 (57,6)
 >90th percentile,  
n (%)
7 (24.1) a 1 (12.5) 1 (11.1) 0 (0.0) 0 (0.0%)
Gender 0.804
Male,  n (%) 15 (51.7) 4 (50.0) 4 (44.4) 10 (66.7) 16 (48.5)
Female,  n (%) 14 (43.8) 4 (50.0) 5 (55.6) 5 (33.3) 17 (51.5)
* Categorical data are presented as n (%) with corresponding Chi2/Fischer’s exact testing. Continuous data 
are presented as a mean (standard deviation) or median (interquartile range) with corresponding ANOVA 
and post hoc Dunnett t-test for pairwise comparisons or Kruskall-Wallis testing and post hoc Mann-Whit-
ney testing for skewed data. a p-value <0.05 versus mild PE pregnancies, b p-value <0.05 versus severe PE 
pregnancies, c p-value <0.05 versus CH. § More than 1 visual complaint including flashes, blurry vision, sco-
toma, blindness and disturbed color vision. NORM, normotensive pregnant women; CH, chronic hyperten-























Figure 2. VePs in normotensive pregnant women
* Each line represents the course of the VEP during the pregnancy of an individual study participant
The latency upper limit, determined in the group of normotensive pregnant women 
was 110 milliseconds (ms) during pregnancy and 113 ms postpartum. The amplitude 
lower limit values were 3.4 microvolts (μV) during pregnancy and 3.9 μV postpartum. 
Figure 3 shows individual VEP latencies of the women in relation to the upper limit, and 
individual VEP amplitudes of the women in relation to the lower limit. Table 2 shows the 
percentage of women with values above or below these limits. A higher percentage of 
women with severe PE had VEP latencies above the upper limit compared to normoten-
sive pregnant women (29.4% versus 0%, P = 0.006). Six to eight weeks postpartum there 
were no differences remaining. Normotensive pregnant women showed a lower mean 
VEP latency during pregnancy compared to their postpartum value (Table 3; 102.89 ± 
3.583 versus 104.86 ± 4.143, P = 0.005). In all other study groups there was no difference 
between the last measurement before delivery and the postpartum VEP value.
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Figure 3. VePs during pregnancy and postpartum
NORM, normotensive controls; CH, chronic hypertension; PIH, pregnancy induced hypertension; mPE, mild 
preeclampsia; sPE, severe preeclampsia. Latency upper limit: 110 milliseconds during pregnancy and 113 
milliseconds postpartum; Amplitude lower limit: 3.4 μV during pregnancy and 3.9 μV postpartum
table 2. Percentage of women with a VeP above the upper limit of latency or under the lower limit of 
amplitude
Latency 
Last measurement before delivery
NOrM (n=29) Ch (n=8) PIh (n=7) mPe (n=14) sPe (n=34)
≥110 ms 0 (0%) 0 (0%) 1 (14.3%) 3 (21.4%) 10 (29.4%)*
6-8 weeks postpartum
NOrM (n=28) Ch (n=8) PIh (n=5) mPe (n=13) sPe (n=24)
≥113 ms 1 (3.6%) 1 (12.5%) 1 (20%) 1 (7.7%) 2 (8.3%)
Amplitude
Last measurement before delivery
NOrM (n=29) Ch (n=8) PIh (n=7) mPe (n=14) sPe (n=34)
<3.4 uV 1 (3.4%) 1 (12.5%) 0 (0%) 0 (0%) 3 (8.8%)
6-8 weeks postpartum
NOrM (n=28) Ch (n=8) PIh (n=5) mPe (n=13) sPe (n=24)
<3.9 uV 1 (3.6%) 0 (12.5%) 1 (20%) 0 (0%) 1 (4.2%)
*Significant difference from NORM group by using Fisher’s Exact Test, P = 0.006
NORM, normotensive pregnant women; CH, chronic hypertension; PIH, pregnancy induced hypertension; 
mPE, mild preeclampsia; sPE, severe preeclampsia; ms, milliseconds; uV, microvolt. 
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Discussion
This is the first study to present VEP data in a relatively large group of pregnant women 
with and without hypertensive complications. Studying neurophysiological parameters 
may be useful in understanding the adaptation of the visual cortex to pregnancy and 
the impact of hypertensive disorders on this system that could contribute to visual 
symptoms. 
VEP latency and amplitude did not change during the course of normotensive preg-
nancy. However, a higher percentage of women with severe PE had VEP latencies above 
the normal values whereas normotensive pregnant women had significantly shorter la-
tencies during pregnancy compared to their postpartum measurements. These findings 
suggest one adaptation of the brain during normal pregnancy is to decrease VEP latency. 
This adaptation appears absent in women with hypertensive disorders of pregnancy.
Studies have previously shown that pregnancy is a state with higher neuronal network 
excitability and a lower seizure threshold (10, 16). However, other neurophysiological 
adaptations such as those occurring in the visual cortex are largely unknown.
Strength of this study is that we were able to retrieve a unique VEP dataset of normo-
tensive pregnant women, which was collected longitudinally. This provided reference 
values in pregnancy. The VEPs were measured in a certified neurophysiological labora-
tory. Relatively large groups of women with mild and severe hypertensive disorders of 
pregnancy were included. A limitation of the study was that most women with severe PE 
delivered soon after recruitment and not all were able to participate in the postpartum 
measurement. This may be caused by the fact that most women with severe PE were 
table 3. VeP latency (mean ± SD) and amplitude (ln(mean±SD)) during pregnancy and postpartum
Latency Last measurement before delivery 6-8 weeks postpartum 
NORM (n = 28) 102.89 ± 3.583 104.86 ± 4.143*
CH (n = 8) 102.38 ± 5.125 105.38 ± 5.317
PIH (n = 4) 104.25 ± 9.878 105.25 ± 6.850
mPE (n = 13) 102.69 ± 8.625 102.92 ± 7.182
sPE (n = 23) 104.87 ± 9.659 105.70 ± 4.656
Amplitude Last measurement before delivery 6-8 weeks postpartum
NORM (n = 28) 2.26±0.41 2.27± 0.41 
CH (n = 8) 2.34±0.67 2.34± 0.33
PIH (n = 4) 2.45±0.25 2.17± 0.75
mPE (n =13) 1.91±0.39 1.90± 0.43
sPE (n =23) 2.00±0.61 2.20± 0.57 
*Significant different from last measurement before delivery by using paired T-test, P = 0.005. 
NORM, normotensive controls; CH, chronic hypertension; PIH, pregnancy induced hypertension; mPE, mild 
preeclampsia; sPE, severe preeclampsia
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referred from other hospitals at a relatively large distance. Although we have data on 
all defined hypertensive disorders of pregnancy, including CH and PIH, we had very few 
cases in these groups. This made it difficult to draw any conclusions about women with 
CH and PIH. This also applies to the correlation of visual complaints with VEPs values, 
because of a lack of power.
There are few older studies available for VEP reference values in the literature. The 
guideline of the American Clinical Neurophysiological Society on VEP refers to older 
published work as well (13). One of those studies produced reference values in only 19 
healthy volunteers of both sexes (17). Another study categorized their reference values 
for age and sex, but included only ten women in the group in the reproductive age (18).
A study in 1991 compared ten third trimester pregnant women to non-pregnant 
women and found reduced latencies in the pregnant women [18]. The authors con-
cluded that normal pregnancy is a state that facilitates conduction process in the optic 
pathways (19). The results of this previous study support findings in the current study 
that normotensive pregnant women neurologically adapt to be more excitable. Nor-
motensive pregnancy is associated with neurophysiological adaptations of the brain, 
including decreased inhibitory gamma-aminobutyric acid type A (GABAA) receptor sub-
unit expression in the cerebral cortex that lowers seizure threshold (8, 10, 20). This may 
be due to high levels of neurosteroids during pregnancy. The adaptation of the visual 
cortex has been studied during PE as well. Marsh et al. studied VEP in non-pregnant 
women, normotensive pregnant women and women with mild PE. This study found that 
normotensive pregnant women had a shorter VEP latency compared to non-pregnant 
women. They did not find differences in latency and amplitude for normotensive preg-
nant women compared to women with mild PE (11, 21). This finding is consistent with 
our finding that VEP latency only differed between normotensive pregnant women and 
women with severe PE.
In summary, we found that the visual cortex adapts neurophysiologically to normoten-
sive pregnancy to have shorter latency of VEPs. This adaptation appears to be absent in 
women with hypertensive disorders of pregnancy, including PE. However, this adapta-
tion can be assessed using neurophysiologic measurements including VEP.
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Abstract
Cerebral perfusion pressure (CPP) is elevated in preeclampsia, and may predispose to 
cerebrovascular complications and progression to eclampsia. We estimated zero flow 
pressure (ZFP) and CPP using simultaneously obtained arterial blood pressure and 
middle cerebral artery blood flow velocity in 10 preeclamptic women, all treated with 
methyldopa ± nifedipine, and 18 healthy pregnant controls. Mean±SD ZFP was lower 
in patients than in controls (16.8±10.9 versus 31.7±15.0 mmHg,p=0.01) whereas CPP was 
considerably higher (82.3±17.7 versus 55.0±11.7 mmHg,p<0.001), as was the cerebral flow 
index (41.9±18.0 versus 25.6±11.2,p=0.02). There was a significant correlation between 
blood pressure and CPP in patients with preeclampsia, but not in controls. Preeclamptic 
women may have an increased cerebral perfusion due to a reduced ZFP and increased 
CPP despite treatment with antihypertensive medication. More rigorous antihyperten-
sive therapy, aimed at reducing CPP, could result in a decrease in cerebral complications 
in preeclamptic patients.
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Preeclampsia complicates 3% of pregnancies and is a major cause of maternal and 
foetal morbidity and mortality (1). Cerebral infarction and haemorrhage account for 
the majority of maternal deaths from preeclampsia. The pathophysiology of cerebral 
damage in preeclampsia is unclear, but recent studies conducted with MRI have shown 
an increased cerebral blood flow in preeclamptic patients (2), and Belfort et al. reported 
patients with severe preeclampsia have an increased cerebral perfusion pressure (CPP) 
(3). High CPP was also shown to be associated with preeclampsia related symptoms 
such as headache, and has also been reported in patients who subsequently developed 
eclamptic seizures.
Currently used drugs in patients with preeclampsia, such as labetalol and MgSO4, 
tend to lower CPP, while nimodipine is associated with a mild increase. Furthermore, 
a randomized study in preeclamptic patients reported that therapy with nimodipine is 
associated with more frequent eclamptic seizures in comparison with MgSO4 (4). These 
findings may be explained by the different effects of these drugs on CPP. 
We aimed to investigate whether CPP, as estimated using simultaneously measured 
arterial blood pressure (ABP) and middle cerebral artery blood flow velocity (Vmca), is 
elevated in preeclamptic patients, in whom blood pressure is adequately treated with 
antihypertensive medication.
Material and Methods
After obtaining informed consent, 10 preeclamptic patients and 18 healthy pregnant con-
trols, admitted to the department of obstetrics of the Erasmus Medical Center, University 
Medical Center Rotterdam, were consecutively enrolled in this study. Preeclampsia was 
diagnosed according to the definition of the International Society for the Study of Hy-
pertension in Pregnancy (ISSHP) (5). Preeclampsia was diagnosed as: hypertension in the 
presence of de novo proteinuria (5). Severe preeclampsia was diagnosed if one or more 
of the following criteria were present: blood pressure of ≥160 mmHg systolic or ≥110 
mmHg diastolic on two occasions at least 6 hours apart; proteinuria of 5 gram or more 
in a 24-hour urine specimen or dipstick urinalysis of 3+ or greater in two random urine 
samples collected at least 4 hours apart; oliguria of less than 500 mL in 24 hours; cerebral 
or visual disturbances; pulmonary edema or cyanosis; epigastric or right upper-quadrant 
pain; impaired liver function; thrombocytopenia; fetal growth restriction (5). Exclusion 
criteria for this study were cerebral vascular disorders, diabetes mellitus, pre-existing 
hypertension and inadequate language skills. The study protocol was approved by the 
Institutional Review Board of the Erasmus MC University Medical Center Rotterdam.
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Transcranial Doppler measurements of the middle cerebral artery flow velocity (VMCA) 
were conducted using a Digi-Lite monitoring system (RIMED, Jerusalem, Israel) using a 2 
MHz probe after identification using the imaging feature. Mean VMCA was estimated as a 
weighted mean velocity. ABP was continuously measured non-invasively using a Finom-
eter Midi (Finapres Medical Systems, Amsterdam, the Netherlands). The Finometer Midi 
allows for easy, non-invasive measurement of ABP using a finger cuff with a mounted 
infrared plethysmograph (6). Expired CO2 was measured using the Capnomac Ultima.
The zero-flow pressure (ZFP) in the circulation is the arterial pressure at which flow 
ceases. Dynamic pressure-flow-plots of the ABP and VMCA have been used to extrapolate 
the ZFP of the cerebral circulation (7, 8). During measurement sessions, a 2 to 5 minute 
time interval with stable measurements was specified on the case record form. For our 
analysis we used systolic and diastolic values from up to 10 pulse waves (two respiratory 
cycles) to minimize the effect of breathing. ZFP was subsequently extrapolated by linear 
regression analysis through the individual measurements (figure 1). The CPP was calculat-
ed as the difference between weighted mean ABP (MAP) and ZFP. CPP was also calculated 
using a formula proposed by Belfort et al(3): CPP = (meanVMCA/(mean VMCA-diastolic VMCA))
x(mean ABP-diastolic ABP). Resistance area product (RAP) is an index of cerebrovascular 
resistance is obtained by dividing MAP by the mean VMCA. Cerebral Flow Index (CFI), an 





















































Figure 1A and 1B
Estimation of the ZFP by extrapolation of simultaneously measured beat-by-beat data on arterial blood 
pressure (systole and diastole) and middle cerebral artery blood flow velocity in a case (A) and a control (B)
SPSS version 15.0 (SPSS Inc., Chicago, IL, USA) was used to perform statistical analyses. 
Results of continuous variables are presented as mean ± SD and results between groups 
were compared using t-tests and chi-square tests. All statistical tests were two-sided 
and were evaluated at the 0.05 level of significance. The study protocol (MEC-2008-035) 
was approved by the Institutional Review Board of the Erasmus MC University Medical 
Center on April 29th 2008
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Age, parity and gestational age at inclusion were similar between patients and controls 
(Table 1). Five patients had severe preeclampsia. All patients were treated with meth-
yldopa; three patients received a combination of methyldopa with nifedipine. One of 
the patients smoked during pregnancy, including the day that the measurements were 
performed, compared to none of the controls. None of the patients developed compli-
cations during follow-up. Gestational age at delivery for cases and controls was 32 ± 4.9 
versus 37.4 ± 3.4 weeks (p=0.012). Patients with preeclampsia had higher ABP and VMCA 
than controls (Table 1). End-tidal CO2 did not differ between cases and controls (41.15 ± 
2.52 versus 41.63 ± 2.97 mmHg, p=0.699). Pulsatility indices of the MCA were 0.47 and 
0.40 in cases and controls (p=0.23).
table 1. A comparison of characteristics and measurements between cases and controls.




           Age (years) 29.9 (2.3) 32.4 (6.4) 0.14
           Nulliparous 7 (70%) 10 (56%) 0.51
           Severe pre-eclampsia 5 (50%) -
           Gestational age at examination (weeks) 30.4 (3.2) 32.1 (3.2) 0.18
           Gestational age at delivery (weeks) 32.3 (4.9) 37.4 (3.4) 0.012
Blood pressure (mmhg)
          Systolic 123.8 (12.7) 101.5 (12.3) <0.001
          Mean 99.1 (9.1) 86.7 (9.3) 0.002
          Diastolic 84.2 (7.7) 78.2 (10.3) 0.12
MCA flow velocity (cm/s)
          Systolic 65.4 (25.0) 49.2 (17.2) 0.05
          Mean 50.7 (19.6) 38.8 (13.5) 0.07
          Diastolic 41.5 (15.8) 33.8 (12.3) 0.16
Cerebral Perfusion 
           Zero Flow Pressure (mmHg) 16.8 (10.9) 31.7 (15.0) 0.01
           Cerebral Perfusion Pressure (mmHg) 82.3 (17.7) 55.0 (11.7) <0.001
           Cerebral Flow Index 41.9 (18.0) 25.6 (11.2) 0.02
           Resistance Area Product 2.30 (1.21) 2.54 (1.04) 0.583
Mean levels of blood pressure, middle cerebral artery flow velocity, zero flow pressure, cerebral perfusion 
pressure and cerebral flow index. MCA, middle cerebral artery. Standard deviations are shown in brackets. 
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Extrapolated ZFP was 16.8 ± 10.9 mmHg in preeclamptic women, compared to 31.7 ± 
15.0 mmHg in controls (p=0.01). Estimated CPP was 82.3 ± 17.7 mmHg in patients com-
pared to 55.0 ± 11.7 mmHg in controls (p<0.001). Consequently, preeclamptic patients 
had a higher CFI than controls (41.9 ± 18.0 versus 25.6 ± 11.2, p=0.02). We have also 
calculated CPP using the method as proposed by Belfort et al. (3): the two measures of 
CPP are highly correlated (r=0.659, p=0.001). Patients also tended to have higher CPP 
than controls when estimated using the Belfort method: 87.1 ± 26.3 vs 70.7 ± 22.1 mmHg 
(p=0.09).
In a multivariate regression model adjusting for parity, gestational age at time of mea-
surement and age at enrolment, patients with preeclampsia had higher CPP both when 
calculated using the regression method (adjusted CPP 83.2 versus 54.5 mmHg, p<0.001) 
and the Belfort method (adjusted CPP 86.1 versus 69.6 mmHg, p=0.036).
In controls, there was no correlation between mean ABP and CPP (r=-0.004, p=0.99), 
but in patients a distinct correlation was found between these parameters (r=0.859, 
p=0.001).
Discussion
The Dutch Maternal Mortality Committee reported cerebrovascular complications to be 
the major cause of death in hypertensive pregnant women (9). Increased CPP has been 
implicated as a possible mechanism to induce a cerebral hyperperfusion syndrome and 
subsequent cerebrovascular complications in preeclamptic patients (2, 3). The CPP in 
our healthy control group compares well with those from other reports, including a 
large study by Belfort et al (10). In the current study, we found that CPP was elevated in 
preeclamptic patients after adequate treatment with antihypertensive therapy. Interest-
ingly, this increase seems to be dependent upon a decrease in ZFP, as opposed to being 
only an effect of the difference in blood pressure between patients and controls. The 
ZFP we found for healthy pregnant controls is compatible with earlier reports (11), but 
whereas Sherman et al. found an increased ZFP in their population of untreated pre-
eclamptics, we found a thoroughly decreased level in our study. A possible explanation 
for this discrepancy is the effect of medication on the ZFP: while the antihypertensive 
agents lowered blood pressure, other cerebrovascular mechanisms may have been 
induced that lowered ZFP, thereby maintaining an elevated cerebral perfusion pressure 
(11). In our study we used methyldopa and nifedipine to lower blood pressure.
CPP in patients with preeclampsia strongly correlates with ABP whereas this correla-
tion is absent in healthy pregnant controls. The elevated CPP was also accompanied by 
an increase in Vmca and CFI. Under normal circumstances, cerebrovascular autoregulation 
would maintain a stable cerebral blood flow, using cerebral vasoconstriction and a sub-
77





sequent change in ZFP, in the face of changes in the systemic circulation. Our findings 
therefore allude to a possible loss of cerebral autoregulation in preeclamptic patients.
A limitation of our study is that we used non-invasive methods for estimation of ZFP 
and CPP. These methods have not been validated in vivo in humans. Given these limita-
tions, we have chosen to use the two most often applied methods for estimation of 
CPP and show that our findings are consistent irrespective of the method used, despite 
varying estimates observed across the methods (supplementary figure 1). The reason for 
the variation is currently unclear, and requires further investigation. Also, preeclamptics 
had a higher ABP than did the controls, despite antihypertensive therapy. This is in line 
with current treatment guidelines and therefore reflects clinical practice (12).
















































Bland-Altman comparison of the two methods for cerebral perfusion pressure estimation. Bold dashed 
lines represent the 95% confidence limits for the difference.
In conclusion, the current study shows that in preeclamptic patients treated with anti-
hypertensive therapy to reduce systolic ABP to <140 mmHg, in line with international 
and Dutch guidelines, CPP and consequently cerebral perfusion are elevated. Possibly, 
more rigorous antihypertensive therapy, aimed at reducing CPP, could therefore result 
in a decrease in cerebral complications in these patients although further studies are 
required to confirm this hypothesis. Future studies on elevated blood pressure control 
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 To define reference values of the patellar reflex in normotensive pregnant and postpar-




University teaching hospital in the Netherlands.
Population
Normotensive non-pregnant women, pregnant women and preeclamptic women.
Methods
In normotensive pregnant women the patellar reflex was cross-sectionally recorded 
using surface electromyography at four time points during pregnancy and 6-8 weeks 
postpartum. In non-pregnant normotensive women this was recorded once. Preeclamp-
tic women were recorded during pregnancy and postpartum. 
Main outcome measures 
Latency and amplitude of the compound muscle action potential of the patellar reflex. 
results 
Latency and amplitude of the compound muscle action potential during normotensive 
pregnancies showed no changes compared to the non-pregnant state during reproduc-
tive age. Latency of the compound muscle action potential was increased in pregnancies 
with severe preeclampsia compared to normotensive pregnancies. Postpartum these 
differences had disappeared. 
Conclusions 
During pregnancy, the patellar reflex can be assessed using surface electromyography. 
Latency and amplitude show no changes during normotensive pregnancies and are no 
different from the postpartum or non-pregnant values.  In severe preeclamptic women 
latency is increased. The clinical value of the latter is limited.  
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Preeclampsia and eclampsia are hypertensive disorders of pregnancy that may be accom-
panied by clinical symptoms of hyperexcitability and cerebral complications. In obstetric 
clinical practice, the patellar reflex is often used in the assessment of preeclamptic patients 
and is believed to predict the risk of an eclamptic fit. The risk of an eclamptic fit is thought 
to correlate with the briskness or augmentation of the tendon reflexes. The impression 
of hyperreflexia is determined by the visual outcome of the patellar reflex, which is re-
flected by the amplitude of the compound muscle action potential (CMAP). The clinical 
management is based on this visual assessment. However, there is large inter-observer 
variability in the semi-quantitative assessment of the routine patellar reflex results (1). This 
semi-quantitative assessment involves a five- to nine-point scoring scale, which assesses 
the amplitude of the reflex visually. The latency (time delay from stimulus to the onset of 
the CMAP) of the reflex cannot be assessed with this subjective method. Moreover, the 
inter-observer variability is likely to be larger during bedside assessment compared to 
the assessment in a study. To reduce inter-observer disagreement, the patellar reflex can 
be objectively quantified by surface electromyography (SEMG) (2). This method measures 
quantitatively the evoked CMAP of a muscle which reflex is initiated. CMAP can be docu-
mented as latency and amplitude of the resulting electrical wave form (Figure 1).
Figure 1. An example of a compound muscle action potential of the patellar reflex.
To date, there are only four publications on normative EMG (electromyography) data 
of the patellar reflex, none of which were conducted during pregnancy and only one 
examined the vastus medialis muscle (3-6). The first purpose of the present study was to 
define reference values of the CMAP of the vastus medialis muscle in healthy pregnant 
women using SEMG and to determine whether the patellar reflex is affected by normo-
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tensive pregnancy. Secondly, we compared these results of normotensive pregnancies 
with those in pregnancies with preeclampsia.
Material and Methods
In this prospective cross-sectional study, normotensive non-pregnant women of repro-
ductive age, normotensive pregnant women and preeclamptic women were recruited 
from the Department of Obstetrics and Gynecology of the Erasmus MC University 
Medical Center, in the Netherlands from October 2005 till July 2008. Normotensive non-
pregnant women were mostly students, workers in the university and university hospital. 
Normotensive pregnant women were out-patients. Preeclamptic women were admitted 
and treated for their raised blood pressure before the measurements. The medical ethics 
committee of the Erasmus MC approved the study and all participants provided written 
informed consent (MEC-2005-142).
In normotensive pregnant women the patellar reflex was cross-sectionally recorded 
using SEMG at four time points during the following gestational age periods: 12-14 weeks, 
26-28 weeks, 32-34 weeks, 36-40 weeks and 6-8 weeks postpartum. In non-pregnant nor-
motensive women the patellar reflex was recorded once. Recordings from preeclamptic 
women were obtained during pregnancy and 6-8 weeks postpartum.
Preeclamptic women were divided into a mild and severe group according to the Ameri-
can Congress of Obstetricians and Gynecologists (ACOG) criteria (7). Severe preeclampsia 
was diagnosed if in addition one or more of the following criteria were present: a blood 
pressure of ≥160 mmHg systolic or ≥110 mmHg diastolic on two occasions at least six 
hours apart; proteinuria of ≥5g in a 24-hour urine specimen or dipstick urinalysis of ≥3+ 
in two random urine samples collected at least four hours apart; oliguria of <500 mL in 24 
hours; cerebral or visual disturbances; pulmonary edema or cyanosis; epigastric or right 
upper-quadrant pain; impaired liver function; thrombocytopenia; fetal growth restriction. 
Antihypertensive medication (methyldopa, labetolol, nifidipine, nicardipine) and magne-
sium sulphate was used according to international guidelines (8). Exclusion criteria were: 
use of contraceptive medication (non-pregnant women), gestational diabetes, diabetes 
mellitus, neurological disorders, muscular diseases and psychiatric disorders.
Patellar reflexes were recorded in all participants using a Viking III P EMG device 
(Nicolet, Madison, Wisconsin, USA). Surface electrodes were used to record the CMAP. 
The negative electrode was placed over the muscle belly of the vastus medialis muscle 
(Figure 2). The positive electrode was placed on the patella. The ground electrode was 
placed laterally just above the knee. The reflex was initiated using a triggering reflex 
hammer wired to the EMG device. It was initiated ten times, in order to reduce influential 
factors, like inaccurate hammering of the patellar tendon and short time fluctuations of 
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central inhibition of the refl ex. The women were positioned on the edge of the examine 
bench in a sitting position. All women were asked to perform the Jendrassik’s maneuver.
During this maneuver the women are asked to interlock the hands to prevent con-
sciously inhibiting or infl uencing the response. This is a method that has also been used 
by other authors (3, 4). This maneuver has an eff ect on amplitude, but not on the latency 
(4). If the patellar refl ex was not measurable in both legs, even with the Jendrassik’s 
maneuver, then women were excluded from analysis. For statistical analysis the highest 
amplitude and the corresponding shortest latency was used.
Figure 2. Placement of the surface electrodes.
All data were analyzed using the statistical software package SPSS 20.0 (SPSS, Chicago, 
IL, USA). To test for normality data were analyzed with the Kolmogorov-Smirnov test. If 
data were normally distributed p-values were obtained with an oneway ANOVA. When 
data were not normally distributed p-values were obtained with a Kruskal-Wallis test. 
Multivariable linear regression analysis was used in data of pregnant and postpartum 
women to test the association between preeclampsia, latency and amplitude. For right-
skewed continuous data a log transformation was performed before linear regression.
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results
During the study period 241 women were consecutively recruited from our in- and outpatient 
clinic. The patellar reflex was recorded in 208 pregnant women (161 normotensive pregnant 
and 47 preeclamptic women) and 33 non-pregnant women. In 12 healthy pregnant women, 
four preeclamptic women and five former preeclamptic postpartum women the reflex was 
recorded, but was not measurable and therefore could not be used in the analysis.
The demographic characteristics of the data are presented in Table 1 and Table 2. Table 
1 shows that the characteristics between the non-pregnant and normotensive gestational 
age groups differed significantly for age, systolic and diastolic blood pressure. When we 
compared the demographics between normotensive and preeclamptic women, there were 
differences seen in weight, systolic and diastolic blood pressure (Table 2). In this group use 
of antihypertensive medication also showed a difference between the groups. When we 
compared the use of medication between mild and severe preeclamptic women no differ-
ence was seen (p=0.277). The postpartum data showed higher systolic and diastolic blood 
pressures and more medication use in formerly preeclamptic women. Between the mild 
and the severe formerly preeclamptic women there were no differences in medication 
use (p=1.000) or other demographic characteristics (age; p=0.278, length; p=0.888, weight; 
p=0.061, BMI; p=0.118, systolic blood pressure in pregnancy; p=0.072, diastolic blood pres-
sure in pregnancy; p=0.179, systolic blood pressure postpartum; p=0.245, diastolic blood 
pressure postpartum; p=0.301). There were no significant differences in latency and ampli-
tude of the CMAP in normotensive pregnancies between the non-pregnant, pregnant and 
postpartum groups (Table 1). Table 2 shows that there was a significant increase in mean 
latency between the three pregnant groups of women concomitant with the severity of 
the hypertensive disorder (p=0.045). The median amplitude decreased simultaneously 
but not significantly. These differences disappeared in the postpartum period (Table 2).
Factors associated with latency and amplitude were examined in multivariable linear 
regression analysis to control for potential confounders (Table 3). Use of antihyperten-
sive medication appeared only to be a confounder for amplitude in pregnancy. Latency 
continues to be significantly different between normotensive and severe preeclamptic 
pregnant women, even when data are adjusted for maternal age and height. Latency 
appeared not to be significantly different in the postpartum group between severe 
preeclamptic compared to normotensive women. After adjusting for age and height 
significance was borderline (p=0.05). In pregnant and postpartum women multivariable 
analysis of amplitude did not show differences between normotensive and preeclamp-
tic women for both crude and adjusted data. The variables height and BMI are highly 
correlated. We choose height as a variable in the multivariable analysis, not the derived 
variable BMI. Effect modification of maternal age, height and antihypertensive medica-
tion in relation to preeclampsia was explored, but not found.
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table 2. Data of pregnant (n=208) and postpartum women (n=71)
Normotensive Mild pre-eclampsia Severe pre-eclampsia p-value
na na na
Demographic characteristics
Pregnant women 161 14 33
Age (years)b 160 33 (19 - 47) 14 33.0 (26.0 - 41.0) 33 29.0 (18.0 – 42.0) 0.270e
Length (cm) c 151 167.5 ± 8.3 14 169.2 ± 6.2 33 168.9 ± 7.0 0.532f
Weight (kg)b 147 67 (46 - 118) 14 78.0 (55.0 – 130.0) 32 69.5 (50.0 – 108.0) 0.034e
BMIb 146 23.5 (16.9 - 
40.7)
14 27.2 (17.4 – 46.1) 32 23.3 (18.4 – 38.3) 0.102e
Systolic blood pressure 
(mm Hg)b
156 110 (90 - 145) 12 133 (110 – 150) 33 140 (105 – 164) 0.000e
Diastolic blood pressure 
(mm Hg)b
156 65 (50 - 90) 12 90 (70 – 95) 33 90 (79 – 110) 0.000e
Use of antihypertensive 
medication d
161 0 (0.0%) 14 9 (64.3%) 31 25 (80.6%) 0.000g
Postpartum women 24 14 33
Age (years)b 24 33.5 (25 - 42) 14 33.0 (26 - 41) 33 29 (18 - 42) 0.331e
Length (cm) c 22 170.4 ± 8.0 14 169.2 ± 6.2 33 168.9 ± 7.0 0.744f
Weight (kg)b 22 71 (50 - 92) 14 78 (55 - 130) 32 69.5 (50 - 108) 0.132e
BMIb 22 23.2 (18.8 - 31.9) 14 27.2 (17.4 - 46.1) 32 23.3 (18.4 - 38.3) 0.232e
Systolic blood pressure 
(mm Hg)b
20 110 (95 - 135) 10 130 (100 - 145) 29 125 (100 - 190) 0.009e
Diastolic blood pressure 
(mm Hg)b
20 70 (50 - 85) 10 85 (65 - 100) 29 80 (50 - 110) 0.010e
Use of antihypertensive 
medication d
24 0 (0.0%) 14 5 (35.7%) 32 11 (34.4%) 0.004g
Latency and amplitude
Pregnant women 161 14 33
Latency (ms) c,h 149 21.29 ± 2.30 12 21.92 ± 1.76 27 22.42 ± 2.08 0.045f,i
Amplitude (mV) b,h 149 2.10 (0.20 - 6.90) 12 1.80 (0.50 - 7.30) 27 1.60 (0.40 - 9.70) 0.172e
Postpartum women 24 14 33
Latency (ms) c,h 24 21.83 ± 2.27 11 21.67 ± 1.65 17 22.23 ± 1.12 0.807f
Amplitude (mV) b,h 24 1.60 (0.30 - 4.50) 11 1.20 (0.40 - 6.30) 17 1.10 (0.40 - 4.50) 0.548e
‘a Number of women from whom the variable was obtained
b Median (range)
c Mean ± SD
d Number (percentage)
e P-values obtained with a Kruskal-Wallis test
f  P-values obtained with a one-way ANOVA test
g P-values obtained with a chi-squared test
h Latency corresponding with the maximal amplitude 
i Significant difference between normotensive pregnant and severely preeclamptic women
Abbreviations:  n, number; cm, centimeters; kg, kilograms; BMI, body mass index; ms, milliseconds; mV, 
milliVolt
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table 3. Multivariable analysis of pregnant (n=208) and postpartum women (n=71)
Outcome measure Crude Adjusted 
B 95% CI P-value B 95% CI p-value
Pregnant women
Latency (ms)a
All PE vs. normotensive .976 .182 - 1.770 0.016 .811 .140 - 1.483 0.018
Mild PE vs. normotensive .626 -.700 - 1.953 0.353 .175 -.923 - 1.274 0.753
Severe PE vs. normotensive 1.132 .207 - 2.056 0.017 1.102 .323 - 1.880 0.006
Amplitude (mV)b,c
All PE vs. normotensive -.088 -.205 - .029 0.140 -.029 -.164 - .107 0.678
Mild PE  vs. normotensive -.020 -.218 - .178 0.839 .025 -.177 - .226 0.810
Severe PE  vs. 
normotensive
-.117 -.253 - .019 0.090 -.057 -.215 - .100 0.474
Postpartum women
Latency (ms)a
All PE vs. normotensive .375 -.985 - 1.735 0.583 .865 -.375 - 2.106 0.167
Mild PE  vs. normotensive .037 -1.764 - 1.838 0.967 .134 -1.413 - 1.681 0.862
Severe PE  vs. 
normotensive
.593 -.971 - 2.158 0.450 1.418 .001 - 2.835 0.050
Amplitude (mV)  b,c
All PE vs. normotensive -.119 -.294 - .056 0.178 -.125 -.327 - .077 0.220
Mild PE  vs. normotensive -.077 -.316 - .162 0.520 -.075 -.330 - .181 0.560
Severe PE  vs. 
normotensive
-.141 -.336 - .054 0.153 -.156 -.380 - .068 0.170
a Adjusted for age (years) and height (cm)
b Adjusted for age (years), height (cm) and use of antihypertensive medication
c  Log transformed data used
Abbreviations: ms, milliseconds; mV, milliVolt; B, regression coefficient; CI, confidence interval; PE, pre-
eclampsia
Discussion
In this study, we present data of the patellar reflex during normotensive pregnancies 
and pregnancies with preeclampsia measured with SEMG. Quantifying the outcome 
of the reflex eliminates the personal interpretation, and standardizes the assessment. 
Our results show that there are no significant differences in latency and amplitude of 
the patellar SEMG during the course of normotensive pregnancies. We were not able 
to show differences during any period in normotensive pregnancies as compared to 
non-pregnant and postpartum pregnancies.  Latency, not amplitude, appeared to be 
significantly different between normotensive and severe preeclamptic women. Age, 
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height and use of antihypertensive medication appeared to be confounding factors. 
Latency continued to be significant even after correcting for these confounding factors.
One article, on normative data of the patellar reflex evoked CMAP in the vastus me-
dialis muscle, contains data of males and females (3). Only five studies were found on 
the patellar reflex during pregnancies with preeclampsia or eclampsia (9-13). However, 
none of these studies used SEMG to quantify the reflex response. Several studies have 
shown that nerve conduction speed decreases with age and therefore has an influence 
on latency (5, 6, 14-16). As shown by many authors, latency is also strongly correlated 
with the height of the individual (4-6, 15, 16). Latency lengthens with increasing height. 
Surprisingly, none of these studies corrected their data for age or height of the individu-
als. Because they did not categorize their data according to sex, age and height we could 
not compare our findings with these data. In Table 1 we show significant differences 
in age and systolic and diastolic blood pressure between the different normotensive 
study groups. In our study all the participants were of reproductive age, ranging from 
20 to 40 years. Although our non-pregnant group was significantly younger than our 
pregnant groups, this difference was not large enough to lead to differences in latency 
or amplitude of the patellar SEMG.
Most studies on the patellar reflexes during pregnancies with preeclampsia suggest 
an increased response as a clinical important hallmark. However, all studies lacked 
quantitative data. The present study is the first to describe these quantitative data, but 
we failed to show an increased response in preeclamptic women. A possible explanation 
is that the blood pressure in all women in our study had been reduced by antihyperten-
sive drugs before the measurements were performed. Also, none of our preeclamptic 
patients developed eclampsia or other serious cerebral complications. Another possible 
disadvantage of this study is the wide range of the measurements, which makes it more 
difficult to show statistically different results. This range is larger during pregnancy and 
especially during pregnancies with severe preeclampsia.
In contrast to what was expected, the latency and, although not significant, ampli-
tude, showed a slower and less pronounced response of the CMAP, also after correction 
for age, height and use of medication. We speculate that the formation of edema, both 
locally and/or in the myelin sheaths may lead to slowing of the nerve conduction. The 
results of the multivariable analysis rule out that antihypertensive medication or mag-
nesium sulphate influence the resting potential of the axons. In the severe preeclamptic 
group of women only 3/29 women received magnesium sulphate during the measure-
ments. The individual data of these three women were not statistically different (data 
not shown).
In conclusion, the patellar reflex can be objectively assessed using SEMG. Gestational 
age has no effect on the patellar reflex during the course of normotensive pregnancy. 
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Assessment of deep tendon reflexes with SEMG in stabilized patients with preeclampsia 
is probably not suitable for clinical bedside assessment and follow-up of preeclamptic 
patients. Future studies regarding the patellar reflex in preeclampsia should address the 
untreated preeclamptic patient.
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Preeclampsia is the most significant cause of neurological symptoms in pregnancy. 
Neurological symptoms may persist even after pregnancy. Somatic symptoms of pre-
eclampsia, such as hypertension and proteinuria, generally disappear after delivery. 
However, formerly preeclamptic women more often complain of cognitive disturbances 
compared to women after uncomplicated pregnancies.
Methods
Three to eight months postpartum, a neuropsychological test battery was performed in 
10 former severely preeclamptic women (according to the guidelines of the American 
College Obstetricians and Gynecologists) and 10 women after uncomplicated normo-
tensive pregnancies. The control group was matched for age, educational level and 
mode of anesthesia. All women delivered by cesarean section either under general or 
regional anesthesia. Tests were performed for premorbid intelligence, short- and long-
term memory, attention, concentration, executive functions, visual and spatial abilities. 
Anxiety and depression levels were measured.
results
The formerly preeclamptic women had significantly lower scores on most indices of 
the auditory-verbal memory test. Formerly preeclamptic patients learned considerably 
fewer words than controls and recalled less after interference. Both case and control 
group did not differ in age, parity or level of education. There were no differences in the 
level of intellectual functioning and language tests, such as naming and word fluency. 
No persistent differences were observed in tests for attention/concentration and execu-
tive functioning. There were no significant differences on depression and anxiety scales.
Conclusions
Maternal memory seems to be impaired after pregnancies complicated by severe pre-
eclampsia. This effect cannot be attributed to depression and/or anxiety or method of 
anesthesia.
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Preeclampsia is a multi-organ disease of unknown cause that is unique to human preg-
nancy. It affects 1-7% of all pregnancies. During the period of clinical disease, laboratory 
tests and imaging techniques are used to assess the condition of the feto- placental 
unit and maternal hemostasis, as well as liver, kidney and lung function. Additionally, 
preeclampsia affects the maternal brain. Cerebral complications, such as eclamptic sei-
zures and hemorrhage, are the main cause of preeclampsia-related maternal deaths (1). 
In imaging studies, eclamptic seizures have been shown to cause permanent cerebral 
damage (2). (Pre-)eclampsia can result in cognitive impairments, such as perceived loss 
of memory and concentration (3). Although these cognitive complaints are usually rela-
tively mild, they can persist, and sometimes interfere with daily functioning and work. 
Unfortunately, little is known about the long-term effects of pre- eclampsia on cognitive 
functioning. To our knowledge, there are no studies published that have systematically 
investigated cognitive functioning with standardized neuropsychological tests postpar-
tum in previously severely preeclamptic patients. Therefore, the objective of this study 
is to compare important cognitive functions  (language, memory, abstraction, atten-
tion, executive functioning and visuoconstruction) 3-7 months after delivery in former 
severely preeclamptic women and women after an uncomplicated pregnancy.
Material and Methods
A case-control study comparing cognitive functions 3-7 months after delivery in 10 for-
mer severely pre- eclamptic patients (case group) and 10 women who had normotensive 
pregnancies (control group), was performed. After obtaining informed consent, patients 
were included in this study from April 2004 to April 2006. The main inclusion criterion for 
the cases was a pregnancy complicated by severe preeclampsia. Severe preeclampsia 
was defined according to the guidelines of the American College of Obstetricians and 
Gynecologists (ACOG; see textbox 1) (4).
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textbox 1. ACOG (4) criteria for severe preeclampsia
Hypertension (systolic blood pressure ≥140 mmHg or diastolic ≥ 90mmHg) and de 
novo proteinuria (≥ 300 mg per 24 h) and the presence of one or more of the follow-
ing criteria:
•	 systolic blood pressure ≥160 mmHg or diastolic ≥110 mmHg on 2 occasions, 
at least 6 h apart while bed rest
•	 proteinuria of 5 g or more in a 24-h urine specimen
•	 oliguria of ≥ 500 ml in 24 h
•	 persistent headache or cerebral or visual disturbances
•	 epigastric  or right upper-quadrant pain
•	 increased serum  creatinine level
•	 impaired liver function
•	 thrombocytopenia
•	 fetal growth restriction
The control group was matched for age, educational level, mode of delivery, and method 
of anesthesia. Patients were excluded when a reliable assessment of cognitive functions 
could not be made due to insufficient command of the Dutch language, severe sensory 
handicaps (e.g. deafness or blindness) or severe psychiatric symptoms. Women who had 
experienced perinatal death were also excluded from the study. None of the pregnancies 
was complicated by eclampsia, pulmonary edema or liver rupture. The case group was 
asked to enroll directly postpartum and the control group 6 weeks postpartum while 
visiting the out-patient clinic. All of the women included, both cases and controls, were 
delivered by cesarean section under general or regional anesthesia. Eight women in 
both groups were delivered under general anesthesia. Five of the women in the control 
group underwent a scheduled cesarean section because of breech position (n =3), vasa 
previa (n =1) and cephalopelvic dysproportion (n =1). The other 5 women underwent an 
emergency cesarean section because of poor progression of labour (n =1), signs of fetal 
distress (n =3) and cephalopelvic dysproportion (n =1).
The neuropsychological test battery was per-formed 3-7 months postpartum when 
the physical complications had largely disappeared and laboratory tests in the patients 
of the case group had normalized. The control group was tested during the same post-
partum period.
As the extent and distribution of the cognitive complaints is unclear, we composed 
a test battery that covers multiple cognitive domains, e.g. premorbid intelligence, 
short- and long-term memory, abstraction, attention, executive functioning, visual and 
spatial abilities. As depression and anxiety are known as the main possible confounders 
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for performance on memory and attention tasks, specific questionnaires were given to 
establish their contribution on the neuropsychological test results.
The Nederlandse Leestest voor Volwassenen (NLV), the Dutch version of the National 
Adult Reading Test, is a reading test of 50 words with irregular pronunciation that pro-
vides an estimation of premorbid level of functioning (5). Auditory verbal memory was 
examined with the Dutch version of the Rey auditory verbal learning test (6). A list of 
15 words is presented orally with 5 learning trials. Delayed free recall and recognition 
followed after 15 min. The Digit Span forward and backward, a subtest of the Wechsler 
Adult Intelligence Scale (WAIS), was used to assess the span of immediate verbal recall, 
but also served as a measure of attentional capacity and working memory (7,8). Patients 
have to repeat a sequence of digits of increasing length in both forward and reverse 
order. The Trail Making Test, and the Stroop Color Word test were also used to measure 
attention (9,10). In the Trail Making Test, patients have to connect either numbers (psy-
chomotor speed), or numbers and letters alternately (concept-shifting). The Stroop Color 
Word Test consists of 3 cards. On the first card, 100 color names (red, blue, green, yellow) 
should be read aloud, on the second card patients have to name the color of 100 printed 
names, all printed in different colors. The color name does not correspond with the color 
of the ink, and patients have to name the color of the ink, and not read the word.  Verbal 
fluency was measured by the number of words mentioned in 1 min. Semantic fluency 
was determined by the number of animals and professions, phonological fluency by 
the number of words starting with a D, A, or T (7).  Scores on verbal fluency, Stroop Color 
Word Test part III and Trail Making Test B served as an indication for the level of executive 
functioning. Visuoconstructive functioning was measured with Block Design, in which 
the patients have to reproduce a printed block design with three-dimensional blocks 
(WAIS) (8) and draw a clock (11). Levels of anxiety and depression were measured by the 
State-Trait Anxiety Inventory (STAI) and Center for Epidemiological Studies Depression 
Scale (CES-D) (12,13). Education was categorized according to the system of Verhage (14), 
which consists of 7 levels of increasing level of education, from 1 (only primary school) 
to 7 (university).
Due to the small sample size, non-parametrical statistical analysis using the Wilcoxon 
rank test was performed using Statistical Package for the Social Sciences (SPSS) 15.0 for 
Windows. A p-value of 0.05 was considered significant.
results
There was no statistical difference between groups in age, parity, level of education, and 
interval between delivery and neuropsychological testing (Table 1). The gestational age 
differed between the 2 groups.
100






median range median range
Age (years) 34.4 29.2-37.4 33.8 29.4-37.2 0.88
Parity (number) 1.4 0-3 1.6 0-3 0.53
Level of education ˚ 5.5 4-7 6 4-7 0.56
Gestational age at delivery (weeks) 30 27-33 38.5 27-41 0.009*
Interval delivery - neuropsychological-testing 
(months)
3.5 3-7 3 3-7 0.75
 Both groups are compared with the Wilcoxon rank test. *P < 0.05 is considered significant
˚ Education was categorized according to the system of Verhage.
The case group had significantly lower scores on most indices of the auditory-verbal 
memory test (Table 2). Former preeclamptic patients learned considerably fewer words 
than controls (50 versus 62), and recalled less after interference (10 versus 14). The pas-
sive recognition condition showed a ceiling effect in both the case and control group.






Median Range Median Range
Intelligence quotient˚ 104 94-115 103 97-111 0.76
Language Boston Naming Test (max. 60) 52 47-57 51.5 35-55 0.55
Semantic Fluency
-animals (no. per 60 sec.) 23.5 19-31 24.5 17-33 0.55
-professions (no. per 60 sec.) 16 8-22 18 13-21 0.13
Phonological fluency (no. per 60 sec.) 32.5 20-46 38 23-53 0.26
Memory Learning (max. 75) 49 43-57 63.5 53-70 0.005*
Recall (max. 15) 10 7-13 14.5 11-15 0.008*
Recognition (max. 30) 30 29-30 30 30-30 0.08
Abstraction Similarities (WAIS) (max. 33) 23 16-29 25.5 19-32 0.06
Attention & executive 
functioning
Letter-number sequencing (WAIS) 
(max. 21)
10 9-13 11 8-14 0.61
Digit span (WAIS) (max. 30) 16.5 12-24 16.5 13-19 0.41
Trail Making Test A (time in sec.) 23.5 15-37 35.5 20-52 0.03*
Trail Making Test B (time in sec.) 49.5 36-75 62.5 46-100 0.20
Stroop, part I (time in sec.) 43 35-69 46 35-108 0.29
Stroop, part II (time in sec.) 56 44-75 59.5 49-89 0.39
Stroop, part III (time in sec.) 81.5 62-115 90 68-122 0.58
Visuoconstruction Block design (WAIS) (max. 68) 39 12-65 38.5 9-63 0.77
Clock drawing (max. 14) 12 11-13 12 10-14 0.38
Personality Depression (CES-D) 7.5 0-32 8 0-21 0.67
Anxiety (STAI-2) 39 20-56 31 20-44 0.21
 Groups are compared with the Wilcoxon rank test.. * P < 0.05 is considered significant.
˚Measured by NLV.
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There were no differences in level of intellectual functioning, regarding the scores 
on the NLV. Language tests, i.e. naming and word fluency, showed comparable scores 
for both groups. In addition, no persistent differences were observed in attention and 
concentration tests, except for a significant difference in favor of the case group for   Trail 
Making Test A. Results on tests for executive functioning were equal in both groups. 
Although the cases had somewhat higher scores on the CES-D (depression) and the 
STAI  (level of anxiety), the differences did not reach significance (CES-D: p =0.67, STAI: 
p =0.21).
Discussion
To date, research of preeclampsia has focused on the etiology, pathogenesis and so-
matic consequences of the disease. However, as somatic symptoms merely disappear 
after delivery, many women continue to complain of cognitive disturbances.
This pilot study shows that memory is impaired in women who suffered from severe 
preeclampsia. The lower scores on the memory measures are consistent over the 
indices. This impairment probably results from the presence of lesions in the brain of 
preeclamptic women due to cerebral ischemia and edema in the clinical phase of the 
disease (15). It is not unlikely that (part of ) the memory deficit may be permanent since 
radiological studies have shown signs of permanent damage in the white matter of the 
brains of patients that suffered eclamptic fits (1). Studies on localization of brain damage 
as a cause of organic amnesia suggest the loss of volume in key brain structures, such 
as hippocampus and thalamus (16). However, it is still not known whether such lesions 
are also present in the brains of severe preeclamptic women. Functional imaging studies 
may provide more insight in localization of this specific type of brain damage.
An alternative explanation for the memory disturbances could be the influence of psy-
chological factors in patients that experienced preeclampsia. These women experience 
an emotional burden of the care for their premature child and their own serious illness, 
which may result in stress and mood changes, such as depression and anxiety. However, 
as in our study scores on depression and anxiety questionnaires were similar in both 
groups, this explanation seems unlikely (Table 2).
The clinical impression of diminished attention and concentration could not be con-
firmed in the formerly preeclamptic patients. In these domains, there were no significant 
differences between the 2 groups, but surprisingly there was a trend towards better 
scores in the case group. One part of the test, the Trail Making Test A, even showed a 
significantly better score by the patient group. As this was an isolated finding in the 
whole domain of attention tests, this is presumably a random result.
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Recent studies on cognitive functioning during uncomplicated pregnancy have 
shown that compared to non-pregnant women, performance on memory tests is de-
creased from early pregnancy to 32 weeks’ postpartum, whereas psychomotor speed 
and executive functioning remains unchanged (17,18). 
Possible explanations for this pregnancy-related memory loss are based on the large 
change in several hormonal systems during pregnancy.
In our present study, an even larger memory deficit was observed in patients after 
pregnancies complicated by severe preeclampsia.
In another recent study, cognitive functioning was studied before and shortly after 
delivery in pre- eclamptic patients and healthy controls (19). In this study, all pregnant 
patients had lower scores on memory measures compared to non-pregnant controls. On 
the other hand, postpartum no statistical differences were found between the patient 
group and the control group in measures for memory and attention, but there was no 
differentiation made between mild and severe preeclampsia.
Although inherent to a pilot study, an obvious restriction of the present study is the 
limited sample size. It is underpowered to detect small differences between groups. It 
could, however, be calculated that our study had sufficient power (80%) to detect dif-
ferences in scores on the learning memory test of ≥6 and the recall memory test of ≥3, 
respectively.
Furthermore, we dealt with the restriction of small sample size by strict matching for 
relevant factors. Since the differences in memory measures are significant and consistent 
over multiple indices, even in these relatively small groups of patients, this finding may 
be considered as a genuine effect of severe preeclampsia. To resolve the major question 
of whether the observed memory deficits are temporary or permanent, al longer follow-
up study is needed.  The long span of 3-7 months between delivery and testing may have 
been a disadvantage. However, considering the findings of a recent study, which found 
no changes in cognitive functioning during a follow-up time of 32 weeks’ postpartum, it 
is unlikely that this played a substantial role (18).
Conclusion
The present study shows that severe preeclamptic patients have at least longstanding 
cognitive function difficulties in especially short- and long-term memory. This may have 
consequences for their postpartum return to normal life and work. It is not clear whether 
this memory deficit can be influenced by earlier intervention or another symptomatic 
treatment of preeclampsia, and can probably be improved by postpartum neuropsycho-
logical training programs. The organic damage causing this memory deficit and whether 
it is permanent or temporary must be elucidated. Severely preeclamptic patients may 
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thus have at least some longstanding cognitive function difficulties in especially short 
and long term memory. This may have consequences for their postpartum return to 
normal life and work. It is not clear whether this memory deficit can be influenced by 
earlier intervention or symptomatic treatment of preeclampsia or whether post partum 
neuropsychological training programs can improve it. It has to be eluded what organic 
damage causes this memory deficit and whether it is permanent or temporary.
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This thesis describes the results of a single center observational study on neurophysi-
ological manifestations in normotensive and hypertensive pregnancies, the ROtterdam 
BRAin function study (the ROBRA study). Various neurophysiological measurements 
were performed both during pregnancy and postpartum.
Preeclampsia is a multi-organ disease of unknown cause that is confined to human 
pregnancy. Preeclampsia affects 1-7% of all pregnancies (1). Neurologic complications 
due to hypertensive disease in pregnancy are among the leading causes of maternal 
morbidity and mortality (2).
In this thesis we used the criteria of the International Society for the Study of Hy-
pertension in Pregnancy (ISSHP), defining pregnancy induced hypertension (PIH) as 
de novo hypertension after 20 weeks of gestation and preeclampsia if hypertension is 
combined with proteinuria (3). The severity of the disease was defined according to the 
criteria of the American College of Obstetricians and Gynecologists (ACOG) (textbox 
1) (4). Stabilization of women with severe preeclampsia was considered to be fulfilled 
after normalization of hypertension by antihypertensive medication and institution of 
anticonvulsive prophylaxis (magnesium sulfate). Stabilization of severe preeclamptic 
patients is of utmost importance to diminish the risks of adverse outcome (1).
textbox 1. ACOG (4) criteria for severe preeclampsia
Hypertension (systolic blood pressure ≥140 mmHg or diastolic ≥ 90mmHg) and de 
novo proteinuria (≥ 300 mg per 24 h) and the presence of one or more of the follow-
ing criteria:
•	 systolic blood pressure ≥160 mmHg or diastolic ≥110 mmHg on 2 occasions, 
at least 6 h apart while bed rest
•	 proteinuria of 5 g or more in a 24-h urine specimen
•	 oliguria of ≥ 500 ml in 24 h
•	 persistent headache or cerebral or visual disturbances
•	 epigastric  or right upper-quadrant pain
•	 increased serum creatinine level
•	 impaired liver function
•	 thrombocytopenia
•	 fetal growth restriction
Preeclampsia may have devastating effects on a women’s health and may lead to severe 
maternal morbidity and even mortality. This is particularly the case when cerebral pa-
thology appears. A definite measure to detect and to follow brain function and possible 
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damage is still not available. It is, however, of great importance to detect this brain dam-
age in an early phase where it may still be reversible.
Clinical signs and symptoms of cerebral manifestations of the disease are headaches, 
eclampsia, visual disturbances and cortical blindness. In the periferal nervous system 
increased tendon reflexes may be observed. Cognitive complaints like memory loss, lack 
of concentration and problems in returning into social life are reported as long term 
complications (5). Depression and anxiety can also be present after preeclampsia (6). 
MRI studies of the brain showed more often white matter lesions after pregnancies 
complicated by eclampsia than after normotensive pregnancies (7, 8) 
The main purpose of our investigations was to develop tools to follow and detect 
changes in maternal brain function during and after pregnancies complicated by hy-
pertensive disease of pregnancy. We chose to use routine neurophysiological tests in 
this thesis. Studies were performed with Electroencephalography (EEG) which gives an 
overview of the brain function with modest spatial but very high temporal resolution, 
evaluating entire brain function, Visual Evoked Potentials (VEP) evaluating the visual 
cortex  and Transcranial Doppler (TCD) evaluating cerebral hemodynamics. To measure 
effects on the periferal nervous system we used Electromyography (EMG) measurements 
of the patellar reflex. 
To study the long term sequelae we repeated the above mentioned neurophysi-
ological tests, and we also performed neuropsychological tests and used questionnaires 
concerning Health related Quality of Life (HRQoL).
Limitations of the study
We live in a well-organized country with easy access to hospitals and hospital care. This 
well-organized care resulted in a study population, which, although by definition were 
having severe preeclampsia, did not suffer from severe complications. For example, 
none of the patients in our study population developed an eclamptic seizure. In our 
Dutch health care system people will often have access to care and get treatment before 
a disease will lead to (extreme) complications. This may have equalized the possible 
differences in the results between our different study groups.
The neurophysiological tests used in this study are not very practical in daily clini-
cal practice. For EEG and VEP examinations, respectively twenty-three and five surface 
electrodes are attached to the skull. To attach and to remove these electrodes is time 
consuming. The whole procedure, including the measurements, lasts one to two hours. 
During the examination, the patient needs to be at rest and the room needs to be quiet 
since noise and other disturbances interfere with the results. For hospitalized pregnant 







cal tests. After the examinations, they meet additional limitations when being almost 
unable to shower to wash the waxes out of their hair, especially when they have 
intravenous and/or arterial lines. Some of the women decided to resign further study 
participation for these very practical reasons.
During the time of our studies we had three obstetrical intensive care beds located in 
one room on our obstetric critical care unit, which was creating a noisy atmosphere. This 
clearly interfered with the measurements and frequently the duration of the measure-
ments had to be extended to obtain results with good quality. For future work, we like to 
use an easier technique with a smaller amount of surface electrodes attached, although 
fewer electrodes will generate less information.
Finally, the inclusion speed in our study was relatively slow due to:
- Restrictions in the availability of an EEG technician in the evenings, nights and week-
ends;
- Many patients did not want to be included in the study when they heard what the 
time investment would be.
electroencephalography
EEG is a technique to measure cortical electrical brain activity. EEG registrations can 
be used to detect epileptic activity, to detect abnormal activity in sleep disorders or 
to detect dysfunctional brain areas after cerebrovascular incidents. EEG is the most im-
portant diagnostic tool in evaluating patients with possible epilepsy. It can support the 
diagnosis of epilepsy but it can also assist in classifying underlying epileptic syndromes. 
Ultimately, EEG is used to detect whether there still is brain activity in comatose patients 
as part of an organ donor procedure. 
In order to make the best clinical use of the EEG, the clinician must understand its 
strengths and limitations.
Limitations of the EEG are:
- EEG patterns are not specific for just one (neurologic) diagnosis;
- A relatively short EEG recording can miss paroxysmal EEG changes;
- EEG may show an abnormal pattern in a healthy person without any disease symp-
toms.
As obstetricians we are interested in the diagnostic use of the EEG during (hyperten-
sive) pregnancies. It is common knowledge that reference values for diagnostic tests 
in pregnancy may be altered due to adaptations of the pregnant body to be able to 
manage the needs of the pregnancy. The brain of healthy women also seems to adapt 
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to pregnancy. Important changes occur at the endothelium and blood-brain barrier, the 
structure and function of the cerebral arteries and arterioles, and cerebral blood flow 
autoregulation (9). Especially cerebral autoregulation remains stable over a broader 
range of the blood pressure in normotensive pregnancies (10). Whether the cerebral cir-
culation becomes involved in the disease process of preeclampsia seems to depend on 
the level of adaptation of the cerebral circulation to pregnancy. In women in whom the 
cardiovascular system including the cerebrovascular circulation is not adapting properly 
during pregnancy, this system may deregulate, resulting in preeclampsia/eclampsia. 
Preeclampsia has an impact on all internal organs, also on the brain. After giving birth 
the changes in these organs normally resolve, but some women will continue to have 
residual signs and symptoms. EEG is a method that can detect (hypoxic) changes in the 
brain when they are still reversible. We investigated whether we could detect these kinds 
of changes in the brain of women suffering from preeclampsia. In our observational 
study we have found lower alpha peak frequencies (chapter 3) in women with severe 
preeclampsia than in the other study groups. A decrease in APF is related to decreased 
performance on memory tasks (11). However, in our study during the postpartum period 
the alpha peak frequency of the women with and without hypertensive disease did not 
differ any more.
Clinical symptoms of preeclampsia typically involve visual symptoms. This may be 
explained by dysfunction of the occipital brain areas. A focal impairment in cerebral au-
toregulation may be the cause of vasodilation and fluid extravasation leading to edema 
(12). We expected to detect EEG abnormalities to be localized in the posterior areas of 
the brain, since there is a lesser degree of adrenergic innervation supporting circulatory 
autoregulation mechanisms possibly leading to more edema. Also, blood pressure, total 
vascular resistance, electrolytes, osmolality and vasoactive peptides might have influ-
ence on excitability of neuronal tissue. The latter effects seem more overwhelming as 
our EEG study showed that women with severe preeclampsia experience a more diffuse 
encephalopathy, with slow wave activities, focal sharp waves and epileptiform activity.
Unfortunately, because of logistic and ethical reasons, we were not able to perform 
EEG’s before or during the start of magnesium sulphate administration. Since this 
medication is always initiated in acute situations, it was not possible to have a neuro-
physiological technician timely available before and during the first hour of admission 
of magnesium sulphate; in most cases simultaneously antihypertensive therapy had to 
be started too. Besides of this, patients had to have some time to decide whether they 
would be willing to participate in this study. Sibai studied EEG’s in women with severe 
preeclampsia already in 1984 and showed that EEG abnormalities persisted during ad-







These findings underline the necessity to seriously consider terminating pregnancy in 
preeclamptic women who develop this diffuse cerebral involvement in order to protect 
them from developing possible permanent neurological damage.
Visual evoked Potential
Our study on VEP showed in normotensive pregnant women neurophysiological adap-
tation to pregnancy of the visual cortex, an adaptation that seemed to be absent in 
women with hypertensive disorders of pregnancy (chapter 4). Studies have previously 
shown that pregnancy is a state with higher neuronal network excitability and a lower 
seizure threshold (9, 14). However, other neurophysiological adaptations such as those 
occurring in the visual cortex, are largely unknown.
Our population size was unfortunately not large enough to demonstrate associations 
between VEP latencies and amplitudes and clinical visual symptoms.  Visual symptoms 
are defined as flashes, scotoma, blurry vision and cortical blindness. As the function of 
the visual cortex is influenced by preeclampsia, VEP is probably a promising method to 
measure brain involvement in preeclampsia. In our study we also performed electro-
retinography (ERG), a method to assess the functioning of the retina itself. In all study 
participants ERG’s were within normal limits. This does not mean that the bloodflow 
in the retina was not influenced by hypertension, but it appears not to result in retinal 
dysfunction as can be assessed with VEP. Doppler studies of the retinal artery during pre-
eclampsia have shown retinal vasospasms associated with visual disturbances (15-18). It 
would be interesting to perform a study combining VEP with Doppler measurements of 
the retinal artery to test differences between hypertensive patients with and without 
visual symptoms.
transcranial Doppler
In our study on cerebral perfusion pressure we found that cerebral perfusion pressure 
is elevated in patients with preeclampsia despite blood pressure normalization treated 
with antihypertensive medication (chapter 5). We also found a strong correlation be-
tween systemic blood pressure and cerebral perfusion pressure in women suffering from 
preeclampsia, suggesting that there is at least a partial loss of cerebral autoregulation. 
This finding confirms the relationship between increasing systolic blood pressure and 
the risk to develop eclampsia, which was clinically demonstrated before (19).
Therefore, we conclude, that it is of upmost importance to regulate blood pressure 
within strict limits because cerebral autoregulation is probably absent or failing. Future 
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intervention studies on blood pressure management during preeclampsia should also 
be aimed to ameliorate cerebral perfusion pressure and cerebral autoregulation.
Patellar reflex
It is common clinical practice to test patellar reflexes to establish neurologic agitation 
and to assess whether women with hypertension are at an increased risk to develop an 
eclamptic seizure. In our study on EMG quantification of the patellar reflex we only tested 
women with severe preeclampsia after stabilization (chapter 6). To our knowledge, this 
is the first study examining quantitatively the patellar reflexes during pregnancy and 
postpartum. Eventually, we had expected to find shorter latencies and higher ampli-
tudes, but we were not able to confirm this assumption. Probably stabilization of the 
patients already decreased the peripheral agitation.
Although these results may suggest clearly limited clinical value of the patellar reflex 
in stabilized patients, it still may be useful to test patellar reflexes in non-stabilized 
patients. The latter has to be investigated.
Neuropsychology and health related quality of life
In a neuropsychological study we showed that both short and long term memory is 
adversely affected in women after a previous severe preeclampsia. Our HRQoL study 
showed that especially social functioning and mental health are hampered in these 
patients. Since cerebral involvement during PE is especially present in the severe cases, 
the EEG abnormalities during preeclampsia may be explained by hypoxic events due to 
edema and/or aberrant perfusion. The resulting cerebral damage might be reflected in 
the cognitive disturbances that were diagnosed.
It is tempting to think that this cognitive impairment of the memory can, at least par-
tially, explain the problems in daily life. Hoedjes et al. showed that formerly preeclamptic 
patients experience symptoms of post-traumatic stress disorder (PTSD) (20). Neonatal 
intensive care admission and perinatal death were other contributing factors to poorer 
HRQoL in these patients (21).
Baecke et al. published a study where they describe that cognitive complaints are 
common among young mothers, but PTSD is more common in preterm preeclampsia 
than in term preeclampsia and preterm birth (22).
The above-mentioned results in all of these studies are in line with studies in other 







health status after critical illnesses (23-27). Preeclampsia has to be considered as one of 
these critical illnesses leading to severe cognitive dysfunction.
Future research suggestions
Because preeclampsia can have such negative physical and mental effects on women’s 
health, future studies should aim on preventive strategies. These strategies should focus 
on the prevention of preeclampsia and/or the prevention of the subsequent morbidity 
due to preeclampsia. In this respect, to improve maternal and fetal outcome in pre-
eclampsia the timing of delivery has further to be optimized. In case of prevention of 
(imminent) cerebral damage one needs a reliable, easy to use measure, especially in the 
phase where the damage is still reversible and can be prevented.
Our new obstetrical unit at the Erasmus MC encompasses an obstetrical critical care 
unit where we are able to provide special care to severely ill pregnant women with cere-
bral and cardiovascular disease and their (often growth-restricted) fetuses. Both mother 
and fetus need dedicated multidisciplinary care of a specialized team. In this team 
perinatologists will work together with anesthesiologists, internal medicine specialists, 
neonatologists, cardiologists, neurologists and psychologists.
The interplay of hemodynamic and neurologic functions has never been investigated 
extensively. This large amount of information can be processed in the present era of 
computerization. In doing so, more insight into the relationship between all these pa-
rameters may be provided and contribute to the elucidation of the pathophysiology of 
preeclampsia. Continuous monitoring prevails over measuring random absolute values 
since it makes trends visible. Using trends instead of absolute values makes it possible 
to introduce personalized medicine. Continuous monitoring with new, easy and non-
invasive methods to measure cerebral function should be developed. The close col-
laboration between the Erasmus MC and Leiden University Medical Center and the Delft 
University of Technology, formalized in the Medical Delta, may provide opportunities to 
develop these new techniques.
As also this thesis has showed, the psychological effects of severe preeclampsia are 
extensive. Women with severe preeclampsia more often deliver their babies prema-
turely. Both hospitalization of the baby and the neurocognitive sequelae of the mother 
will negatively influence their bonding (28). Currently, adequate programs to improve 
bonding between mother and baby are lacking. There is a strong need to develop and 
evaluate feasible programs which improve this aspect of motherhood.
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This thesis intends to describe and explain the course of clinical neurophysiological and 
neuropsychological parameters in patients with hypertensive disorders in pregnancy. 
We aimed to improve knowledge on cerebral pathophysiological mechanisms of pre-
eclampsia related to signs and symptoms and to explore whether measuring features 
of these mechanisms with neurophysiological techniques can help to optimize timing 
of delivery in order to minimize maternal morbidity and maximize neonatal outcome.
A review on 22 articles (chapter 2) describe the electroencephalogram (EEG) during 
pre-eclampsia (PE)/ eclampsia. Abnormal EEG findings were observed in the majority 
of the pre-eclamptic/eclamptic patients, consisting of slow waves most frequently lo-
calized in the occipital lobe, as well as spike discharges. The EEG abnormalities in PE/
eclampsia were reversible in the majority of the cases. Most of the retrieved articles 
were published in the 1950s and 1960s and were not consistent with current clinical 
guidelines or medical terminology.
Therefore, we conducted our own study on EEG (chapter 3). We compared EEG find-
ings during pregnancy and postpartum in women with normotensive pregnancies and 
pregnancies complicated by hypertensive disorders.
EEG’s were recorded on several occasions during pregnancy and 6-8 weeks postpar-
tum. Postpartum, the women filled out health related quality of life questionnaires. 
In women with severe preeclampsia significantly lower alpha peak frequency, more 
delta and theta activity bilaterally and a higher EEG Sum Score were seen. Abnormalities 
showed diffuse cerebral involvement and were not predominantly confined to the oc-
cipital areas. Postpartum, these women showed impaired mental health, mental fatigue 
and social functioning, which could not be related to the EEG findings. We concluded 
that women with severe PE show more EEG abnormalities and have impaired mental 
wellbeing postpartum, but these findings are not correlated.
In the next chapter (chapter 4) we present a study on visual evoked potentials (VEPs). 
VEP measure the functional neuronal integrity of the visual pathway from retina to the 
occipital cortex of the brain. The objective of this study was to compare neurophysiologi-
cal changes in women with hypertensive disorders of pregnancy using VEPs. We defined 
reference values for normotensive pregnant women. Normotensive pregnant women 
had a shorter latency during pregnancy compared to their postpartum value. Women 
with severe preeclampsia had a prolonged latency of VEPs compared to normotensive 
pregnant women, a difference that disappeared postpartum. We concluded in this study 
that normotensive pregnant women show neurophysiological adaptation to pregnancy 
of their visual cortex, which seemed to be absent in women with hypertensive disorders 
of pregnancy.
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Using Doppler ultrasound (chapter 5) we estimated zero flow pressure (ZFP) and cere-
bral perfusion pressure (CPP) using simultaneously obtained arterial blood pressure and 
middle cerebral artery blood flow velocity in women with preeclampsia, all treated with 
methyldopa ± nifedipine, and healthy pregnant controls. Mean ± SD ZFP was lower in 
patients than in controls whereas CPP was considerably higher, as was the cerebral flow 
index. There was a significant correlation between blood pressure and CPP in patients 
with PE, but not in controls. Women with PE may have an increased cerebral perfusion 
due to a reduced ZFP and increased CPP despite treatment with antihypertensive medi-
cation. More rigorous antihypertensive therapy, aimed at reducing CPP, could result in a 
decrease in cerebral complications in women with PE.
In normotensive pregnant women the patellar reflex was cross-sectionally recorded 
using surface electromyography at four time points during pregnancy and 6-8 weeks 
postpartum (chapter 6). In non-pregnant normotensive women this was recorded once. 
Preeclamptic women were recorded during pregnancy and postpartum.  Latency and 
amplitude of the compound muscle action potential during normotensive pregnancies 
showed no changes compared to the non-pregnant state during reproductive age. 
Latency of the compound muscle action potential was increased in pregnancies with 
severe preeclampsia compared to normotensive pregnancies. Postpartum these differ-
ences had disappeared.
Women after PE more often complain of cognitive disturbances compared to women 
after uncomplicated pregnancies. We performed a study with a neuropsychological test 
battery in women who have had severe PE and women after uncomplicated normoten-
sive pregnancies (chapter 7). The control group was matched for age, educational level 
and mode of anesthesia. All women delivered by cesarean section either under general 
or regional anesthesia. The formerly pre-eclamptic women had significantly lower scores 
on most indices of the auditory-verbal memory test. Formerly pre-eclamptic women 
learned considerably fewer words than controls and recalled less after interference. 
Study groups did not differ in parity. There were no differences in the level of intellectual 
functioning and language tests, such as naming and word fluency. No persistent dif-
ferences were observed in tests for attention/concentration and executive functioning. 
There were no significant differences on depression and anxiety scales.
In chapter 8 the general discussion reflects on limitations in our studies. It relates 








Dit proefschrift beschrijft en verklaart het verloop van klinisch neurofysiologische en 
neuropsychologische parameters bij patiënten met hypertensieve ziekten in de zwan-
gerschap. Het doel is om onze kennis over cerebrale pathofysiologische mechanismen 
bij preeclampsie te verbeteren in relatie tot de symptomen. We willen onderzoeken 
of  kenmerken van hypertensieve ziekten gemeten met klinisch neurofysiologisch 
onderzoek kan helpen bij het optimaliseren van het moment van de bevalling ten einde 
maternale morbiditeit te minimaliseren en neonatale outcome te maximaliseren.
Een review over 22 artikelen over elektro-encefalografie (EEG) bij (pre-) eclampsie 
wordt in hoofdstuk 2 beschreven. In een groot deel van de patiënten met (pre-) eclamp-
sie worden abnormale EEG bevindingen waargenomen, bestaande uit trage golven en 
pieken in voornamelijk de occipitaalkwabben. Bij een groot deel van de patiënten waren 
de afwijkingen reversibel. De gevonden artikelen waren van oudere datum (gepubli-
ceerd in de jaren ’50 en ’60 van de vorige eeuw) en kwamen niet meer overeen met 
de huidige richtlijnen en er werd verlaten medische terminologie gebruikt. Hierdoor 
vonden we het relevant om een eigen studie over EEG te verrichten.
Deze studie wordt in hoofdstuk 3 beschreven. We verrichtten een studie over EEG 
bij gezonde normotensieve zwangeren, bij vrouwen met chronische hypertensie en bij 
vrouwen met hypertensieve ziekten in de zwangerschap. We hebben de bevindingen 
van de EEG’s vergeleken zowel tussen de groepen in de zwangerschap als met de 
postpartum bevindingen (6-8 weken postpartum). Verder vulden de geïncludeerde 
vrouwen postpartum een vragenlijst in met vragen over “health related quality of life”. 
Bij vrouwen met ernstige preeclampsie werd er in de zwangerschap een significante 
lagere alfa piek frequentie, bilateraal een toegenomen hoeveelheid delta en theta ac-
tiviteit en een toegenomen Sum Score gevonden. De gevonden afwijkingen kwamen 
bij ernstige preeclampsie diffuus door het cerebrum voor en niet voornamelijk in de 
occipitaalkwabben.
Post partum toonden deze vrouwen een verminderde mentale gezondheid, toege-
nomen mentale vermoeidheid en verminderd sociaal functioneren.  Deze bevindingen 
correleerden niet met de gevonden EEG afwijkingen. We concludeerden dat vrouwen 
met een ernstige preeclampsie meer EEG afwijkingen en post partum een slechtere 
mentale gezondheid vertonen dan vrouwen in de andere onderzoeksgroepen.
In het volgende hoofdstuk (hoofdstuk 4) presenteren we een studie over visual 
evoked potentials (VEPs). VEP meet  of de neurologische visuele banen van oog tot her-
senschors intact functioneert. Het doel van deze studie was om de uitkomsten van VEP’s 
te vergelijken tussen gezonde normotensieve zwangeren, vrouwen met chronische 
hypertensie en vrouwen met hypertensieve ziekten in de zwangerschap.
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We hebben referentiewaarden voor gezonde normotensieve zwangeren gedefini-
eerd. Deze vrouwen toonden een kortere latentietijd tijdens de zwangerschap dan post 
partum. Vrouwen met ernstige preeclampsie toonden een verlengde latentietijd ver-
geleken met gezonde normotensieve zwangeren. Dit verschil verdween post partum. 
Hieruit concludeerden we dat gezonde normotensieve zwangeren een neurofysiologi-
sche aanpassing vertonen in de zwangerschap die niet aanwezig blijkt bij vrouwen die 
hypertensieve ziekten in de zwangerschap ontwikkelen.
In hoofdstuk 5 hebben we met Echo-Doppler de zero flow pressure (ZFP) en cerebrale 
perfusiedruk (cerebral perfusion pressure (CPP)) bepaald door gelijktijdig de arteriële 
bloeddruk en de stroomsnelheid door de arteria cerebri media te meten bij vrouwen met 
preeclampsie en gezonde normotensieve zwangeren. Alle vrouwen met preeclampsie 
werden behandeld met methyldopa met of zonder nifedipine. De mean ± SD ZFP en 
de cerebrale bloedstroom index was lager bij patiënten met preeclampsie dan bij de 
gezonde normotensieve zwangeren.
Er was een significante correlatie tussen de bloeddruk en de CPP bij patiënten met 
preeclampsie; deze correlatie bestond niet bij de gezonde normotensieve zwangeren.
Het kan zijn dat vrouwen met preeclampsie een toegenomen cerebrale perfusie 
hebben door de afgenomen ZFP en de toegenomen CPP ondanks dat zij adequaat met 
antihypertensieve therapie worden behandeld. Bij de gezonde normotensieve zwan-
geren cross-sectioneel de kniepeesreflex gemeten met oppervlakte elektromyografie 
op 4 momenten in de zwangerschap en post partum (hoofdstuk 6). Bij de gezonde 
niet-zwangere vrouwen werd op een moment de kniepeesreflex gemeten. Bij vrouwen 
met preeclampsie werd de meting een keer tijdens de zwangerschap en een keer post 
partum gemeten. De latentietijd en de amplitude van de niet-zwangere en de gezonde 
normotensieve zwangere vrouwen toonden geen verschillen. De latentietijd van de 
vrouwen met preeclampsie was toegenomen ten opzichte gezonde normotensieve 
zwangere vrouwen. Post partum was dit verschil verdwenen. 
Na een zwangerschap gecompliceerd door preeclampsie klagen vrouwen vaker over 
cognitieve problemen dan na een ongecompliceerde zwangerschap. Wij hebben een 
studie gedaan met neuropsychologisch onderzoek bij vrouwen na ernstige preeclamp-
sie en na een normotensieve zwangerschap (hoofdstuk 7). De groepen werden gemat-
ched voor leeftijd, opleidingsniveau en soort anesthesie. Alle vrouwen in de studie zijn 
per sectio caesarea bevallen onder regionale of algehele anesthesie.
De vrouwen die een preeclampsie hadden doorgemaakt hadden significant lagere 
scores op de meeste indices van de geheugentest.  Zij leerden aanzienlijk minder woor-
den dan de gezonde vrouwen. De groepen verschilde niet in pariteit. Het intellectueel 
functioneren verschilden niet tussen de groepen. Het taalgebruik was even vloeiden 







tratie en executief functioneren testen. Er waren geen significante verschillen in depres-
sie en angst.
In hoofdstuk 8 wordt de generale discussie beschreven en wordt gereflecteerd op 
de problemen en beperkingen van onze studies. De bevindingen worden in klinisch 
perspectief geplaatst en er worden aanbevelingen gedaan voor vervolgonderzoek.
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